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TESTING THE EFFECTIVENESS OF BEHAVIORAL ACTIVATION
THERAPY IN THE TREATMENT OF ACUTE
UNIPOLAR DEPRESSION

Jenifer M. Cullen, Ph.D.
Western Michigan University, 2002
The present study sought to investigate the clinical effectiveness o f Behavioral
Activation (BA) Therapy, the behavioral activation component o f Beck's Cognitive
Therapy (CT; Beck, Rush, Shaw, & Emery, 1979). Seventeen adults seeking mental
health services for Unipolar Depression were recruited from the Kalamazoo and
Southwestern Michigan regions. All participants were randomly assigned to either
(a) an Immediate Treatment Group, or (b) a w aitlist control group, while both
received 10 weeks o f BA therapy. Depressive symptomatology for both conditions
were assessed at pretreatment, post-treatment, and 3-month follow-up with the Beck
Depression Inventory-II (BDI-II; Beck, Steer, Ball, & Ranieri, 1996), the Structured
Clinical Interview for the DSM-IV-Non-Patient Version (SCID; First, Spitzer,
Gibbon, & Williams, 1997), and the Revised Hamilton Rating Scale for Depression
(RHRSD; Warren, 1996). It was hypothesized that at the completion o f treatment,
participants in both the immediate treatment and w aitlist conditions would be
significantly less depressed both on a self-report measure and on clinician ratings o f
severity o f depression. It was further hypothesized that the waitlist participants
would show no significant change during the w aitlist period.
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CHAPTER I

INTRODUCTION
Unipolar Depression is a serious and debilitating mental disorder that afflicts a
large number o f human beings worldwide. According to a National Comorbidity
Survey in the USA (Blazer, Kessler, McGonagle, & Swartz, 1994), approximately
4.9% o f the population suffers from Unipolar Depression. This means that at any
given moment approximately 1 person in 20 is significantly depressed. Not only is
depression fairly widespread at any given time, but its lifetime prevalence is also
high. The National Comorbidity Survey indicates a lifetime prevalence rate o f 17%
and a 12-month prevalence rate o f 10.3% (Blazer et al., 1994; Hammen, 1997). As
noted by Lecrubier(200l), these numbers are expected to increase over the coming
decades. It has been estimated by the World Health Organization (WHO) Global
Burden o f Disease Survey that by the year 2020, major depression will be second
only to heart disease. Although depression is highly prevalent, it is difficult to know
exactly how many individuals suffer from depression at any one time. It seems these
numbers may be underestimated since only about 70% o f individuals with depression
seek treatment (Angst, 1998).
W hile depression directly afreets many people in the USA, even those in
society who are not direct victims are impacted. For instance, occupational
productivity is directly impacted b y depression. According to Mintz, Mintz, Arruda,
1
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& Hwang (1992), the workplace cost o f depression in the USA in terms o f lost tim e at
work is estimated at more than 172 million days yearly. When such loss o f
productivity is combined with an increase in health care services associated with the
disorder, the costs o f depression become astronomical. According to the National
Institute o f Mental Health, economic costs reach approximately $27 billion annually.
Today, depression continues to be a challenging mental health problem that is worthy
o f much attention (Robinson, Wischman, & Del Vento, 1996).
When Emil Kraeplin first described depression in the early 1800’s, it was
characterized as a disease. Today we know that depression is not something
somebody has, but is more a feeling that one experiences for some period o f time.
Some o f the common mental states and behaviors that accompany depression include,
but are not limited tor feeling guilty, burdened, and/or dysphoric, problems interacting
with others, low levels o f activity, and various physical problems. In order to be
formally diagnosed with Unipolar Depression, as operationalized by the Diagnostic
and Statistical Manual o f Mental Disorders (4th Edition; DSM-IV; American
Psychiatric Association, 1994), an individual must experience a 2-week period o f
dysphoric mood or loss o f interest o r pleasure, and at least four other symptoms that
m ay include: (a) significant weight loss or gain; (b) appetite disturbance; (c) insomnia
or hypersomnia; (d) psychomotor agitation or retardation; (e) fatigue o r loss o f
energy; (f) feelings o f worthlessness; (g) inappropriate guilt; (h) impaired
concentration; and (0 recurrent suicidal ideas o r a suicide attempt.

2
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These core symptoms o f a depressive episode are the same for children,
adults, and die elderly, although every individual who suffers from depression does so
in their own unique way. Furthermore, there are large individual differences as to
which feelings o r behaviors accompany the disorder, and the extent to which an
individual experiences these symptoms varies widely from person to person
(Lewinsohn, Munoz, Youngren, & Zeiss, 1978).
Etiological Components o f Unipolar Depression
There have been a number o f principles and conceptualizations introduced
over the past century to explain the etiology o f depression. One theory that precisely
explains the etiology o f depression, and is backed by numerous years o f empirical
research, is the behavioral conceptualization. Ferster (1966) has put forth one such
theoretical explanation worthy o f discussion. He described several hypothetical
mechanisms by which depression can occur, the first being the assumption that the
m ajor feature o f depression is a reduced frequency o f adaptive behavior. The
environmental events potentially responsible for this reduction are instances when
excessively large amounts o f adaptive behavior are required before reinforcement is
provided o r when there is an absence o f reinforcement, aversive stimuli or
punishment, and finally, a sudden change in the environment (e.g., death o f a loved
one). Ferster adds that the common denominator o f all the above mechanisms is a
decrease in the rate o f positive reinforcement for adaptive behavior. According to
Lewinsohn, Sullivan, & Grosscup (1980), there are three general reasons why a
3
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person m ay experience low rates o f positive reinforcement. First, the person’s
immediate environment may have few available positive reinforcers. Second, the
person may lack the skills to obtain available positive reinforcers. Finally, the
positive reinforcement potency o f events may be reduced.
These changes in the frequency or sources o f positive reinforcement can be
viewed as the environmental antecedents o f depressive symptoms and behaviors.
Once these depressive behaviors manifest themselves, they may be maintained by
reinforcement from others (the secondary gain phenomenon), and in turn
strengthened by their consequences (Lewinsohn, Weinstein, & Alper, 1970). For
instance, the individual who mopes around, complains about somatic symptoms, and
agonizes over his o r her unhappiness generates reactions from the environment that
may take the form o f sympathy, concern, interest, or suggestions. This positive
attention can then inadvertently reinforce depressive behavior.
Ultimately, as the depressed individual becomes increasingly dysphoric and
depressed, when the opportunity arises to come in contact with positive
reinforcement, inappropriate behavior m ay surface (e.g., complaining incessantly
about their mood). Close friends and fam ily may then begin to see these individuals
as aversive, thus ignoring future contacts and further decreasing the frequency o f
rewards available in the environment. This in turn aggravates the depressed person’s
own self-rejection and s e lf criticism , and leads to further isolation. This vicious cycle
m ay continue until one is so depressed that he o r she is resistant to attempts made by
others to help him by showing love and friendship (Bandura, 1977).
4
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Contrary to the behavioral etiological conceptualization for depression is the
cognitive etiological theory. Whereas the behavioral view states that a depressed
person’s behavior is what causes the following despondent emotion o r thought, the
cognitive conceptualization would argue that depressive thoughts or emotions
precede corresponding depressive behavior, and if one can alter negative thoughts or
emotions more positive behavior patterns will follow. Beck’s cognitive theory o f
depression (Beck, Rush, Shaw, & Emery, 1979) has been the most thoroughly
researched approach in the cognitive arena (Taylor & Marshall, 1977). Beck’s theory
o f depression focuses on the strong relationship between thinking and depression. In
Beck’s view, a depressed individual consistently thinks he or she is deficient and
inadequate, and life experiences are consistently construed in a negative way. It is
these erroneous beliefs and maladaptive information processing that eventually play a
role in the onset and maintenance o f depressive episodes (Kovacs & Beck, 1978).
More specifically, Beck et al. (1979) proposed that there are three concepts
that define the etiological components o f depression. These components include: (1)
the cognitive triad, (2) schemas, and (3) cognitive errors (faulty information
processing). The concept behind the cognitive triad explains that depressed people
typically follow three negative cognitive patterns. First, depressed people regard
themselves in a negative manner. More specifically, they feel defective, inadequate,
diseased, or worthless. Second, depressed people interpret their ongoing life
experiences in a negative way. They believe they cannot attain their goals because
the world makes exorbitant demands on them. Furthermore, interactions w ith the
5
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environment are misinterpreted and the person is left feeling defeated or deprived.
Finally, depressed people see their future in a negative light. Further difficulties are
anticipated, while hardship, frustration, and deprivations are expected to plague them.
The second major element in Beck’s cognitive model o f depression
incorporates the concept o f schemas. According to Beck et al. (1979), schemas are
stable cognitive patterns that are used to screen out, differentiate, and code the stimuli
that confront us daily. Experiences thus become categorized and evaluated through a
matrix o f schemas. People suffering from depression are said to possess a dormant
cognitive schema. This schema may then become active under conditions o f stress
that are related to experiences initially responsible for embedding the negative
attitude. Once activated, this schema influences the way information is processed and
people lose voluntary control over thinking processes. Other m ore appropriate
schemas are then unable to be evoked (Kovacs & Beck, 1978; Beck et al., 1979).
The final m ajor element that Beck et al. (1979) recognizes as critical in a
discussion o f cognitive factors o f depression is faulty information processing. The
depressed person perceives their present, future, and outside world (the cognitive
triad) in a negative light. It is these systematic errors in thinking that maintains their
beliefs they are worthless, inadequate, etc. More specifically, depressed people have
a tendency to make broad global statements regarding the events in their lives, and
the meanings they give to these events are “extreme, negative, categorical, absolute,
and judgmental” (Beck et al., 1979, p. 14). The depressed person consequently leads
a biased rendition o f then: life experiences and expects to fail at anything they
6
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undertake, all the while engaging in a tremendous amount o f s e lf criticism (Beck et
al., 1979).

Behavior Therapy Treatment Modalities
Because both the behavioral and cognitive conceptualizations o f depression
have been supported with many years o f clinical and empirical evidence (Beck et al.,
1979; Steinbrueck, Maxwell, & Howard, 1983; Dobson, 1989; McLean, Ogston, &
Grauer, 1973), successful treatment modalities for each have followed. W hile there
are noted similarities between these two modalities o f treatment (Beck, 1970), each
helps the depressed individual in a unique way. The behavioral treatment o f
depression is based primarily on learning theory and its therapeutic goal is to change
the contingencies that initiate and maintain depressive behaviors. According to
Kovacs (1979), the traditional behavioral therapy for depression essentially seeks to
increase the frequency o f socially desirable behaviors, while at the same tim e
decreasing the rate o f undesirable ones. Teaching the client the necessary skills that
will enhance the ability to come in contact with positive social reinforcers can do this.
Many successful behavioral interventions have therefore been adopted that have
allowed the behavioral therapist to institute those that are best suited for the
individual client.
Therapeutic techniques that help an individual restore an adequate schedule o f
reinforcement by increasing activity levels are both common and instrumental in
decreasing depressive symptoms (Lewinsohn e t al., 1980). “Behavioral activation”
7
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employs the well-known idea that being active leads to rewards that are antidotes to
depression (Hammen, 1997, p. 142). As noted by Beck et al. (1979), people who are
depressed typically participate in a great deal o f social withdrawal and avoidance on
the basis that activity and social interaction are meaningless, not interesting, or that
others see them as a burden. They criticize themselves for their withdrawal and lack
o f motivation, which thereby adds to feelings o f inadequacy and helplessness. As a
result, remaining inactive becomes part o f a vicious cycle that is difficult to break out
of.
One such intervention that decreases a client’s passivity and inactivity
involves the therapist and patient collaborating to construct a daily activity schedule.
Essentially, specific hour-by hour activities are planned throughout the day and the
client monitors and records these completed activities on a record form. Constructing
specific goal-oriented tasks not only shows the client that he or she is capable o f
setting and accomplishing goals, but also provides the therapist and client with
concrete data from which to base assessments o f the patient’s functional capacity
(Beck et al., 1979).
To supplement the activity schedule, a “graded task” hierarchy may be
incorporated into the daily plan (Beck et al., 1979, p. 121). Graded task assignments
are stepwise tasks or activities that help clients progress to completing more difficult
assignments as the simpler ones are mastered (Hammen, 1997). A fter the successful
completion o f a task, the patient usually foels motivated to move onto the next step.

8
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Repeated successes generally begin to undermine the feelings o f inadequacy and
worthlessness that fuel one’s inactivity (Beck et al., 1979).
W hile it is important that a depressed individual remain behaviorally
activated, it is also important for a client to derive some pleasure from these activities
and tasks. According to Beck et al. (1979), some depressed patients engage in
activities, but procure very little pleasure from them. One reason for this may be their
“selective inattention to sensations o f pleasure” (Beck et al., 1979, p. 128). Mastery
and Pleasure techniques have thus been designed to drive a patient to undertake a
particular pleasurable activity for a specified number o f minutes each day. Changes
in mood and reductions in depressive symptoms associated with the pleasurable
activity are recorded by the patient. More specifically, it is helpful if the patient rates
their degree o f Pleasure (P) and Mastery (M), which refers to their sense o f
accomplishment when performing a particular task or activity. As a result, these
ratings rivet one’s attention to the enjoyment they are deriving from the participation
in and completion o f activities (Beck et al., 1979).
Interventions that have been aimed at improving depressed patients’ social
and assertive skills are also common in the behavioral therapeutic process. As
mentioned previously, depressed individuals typically have a tendency to slip into
social isolation, becoming increasingly passive as their opportunities to interact
socially become fewer and fewer (Beck et al., 1979). Social skills training seeks to
increase the frequency o f adaptive behaviors associated with positive social
reinforcement. Furthermore, so that depressed individuals can extract m ore positive
9

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

reinfbrcers from their lives, assertiveness skills (e.g., role-playing) m ay also be taught
(Lewinsohn, Antonuccio, Steinmetz, & Ten, 1984).
Cognitive Therapy Treatment Modalities

Along with BT, Cognitive therapy (CT) has also established itself as an
effective short-term therapy for clinical depression (Dobson, 1989). The cognitive
therapy o f depression, developed by Beck and his associates (Beck et al., 1979), is a
specific type o f the broad class o f therapies called cognitive behavioral (Dobson &
Block, 1988). Contrary to the emphasis in behavioral treatment for depression, CT is
based on the premise that introspective data (i.e., thoughts, feelings, wishes,
daydreams, attitudes) provide a wealth o f information that the therapist can use as the
principal target for therapeutic work (Beck, 1970). Unlike behavior therapy which
focuses on the overt behaviors o f its clients, CT focuses on a set o f operations that
center around “a client’s cognitions (verbal o r pictorial) and on the premises,
assumptions, and attitudes underlying these cognitions” (Beck, 1970, p. 187).
Because a cognitive psychologist believes that dysfunctional thought patterns are
what fuels one’s depressive symptoms, CT focuses to change the client’s
misinterpretations, self-defeating behavior, and dysfunctional attitudes. The client is
taught to identify his o r her faulty cognitions and recognize the crucial link between
negative antecedent thoughts and the subsequent negative feelings that follow
(Kovacs & Beck, 1978).

10
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According to Beck et al. (1979), because this relationship between negative
cognitions and unpleasant emotions is so strong, CT relies heavily on “emotional
techniques” as part o f its therapeutic repertoire (p. 36). The following is a list o f
operations that may be included in CT. While not exhaustive, this slate o f
interventions is designed to delineate and test the client’s specific misconceptions and
maladaptive assumptions.
As Beck et al. (1979) notes, the first and most critical intervention involves
the self-monitoring o f “automatic thoughts.” Automatic thoughts come out o f the
blue, unprompted by events and are not necessarily the result o f ‘directed’ thinking.
These thoughts are typically immediate and are valid in the sense that the individual
accepts them as true without further analyzing them. Automatic thoughts spawn
further thoughts and images to emerge and cause a “downward spiral o f despair”
(Clark & Fairbum, 1997, p. 263). To target these automatic thoughts, the therapist
trains the client to observe, define, and record the negative cognitions. Through inbetween session assignments, the relationship between cognition and affect are
demonstrated, using specific, real-life examples. Once a client leams to detect as
many negative automatic thoughts as possible, the client and therapist can work
together to examine the evidence for and against these distorted automatic thoughts.
W ith the help o f the therapist, more pragmatic and reality-oriented interpretations for
these biased cognitions can then be substituted. W hile the depressed person
characteristically views the world in a negative light, the goal here is to encourage a
m ore accurate description o f the way things truly are. Finally, as the client leams to
11
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identify, challenge, and alter these dysfunctional beliefs, a decrease in depressive
symptoms may follow (Beck et al., 1979).
W hile there are obvious differences between the behavioral and cognitive
treatments for depression, these two systems o f psychotherapy share many
similarities and are often blurred. First, in both the behavioral and cognitive
paradigms, clients are trained to initiate, conduct and evaluate their own treatment,
with the guidance o f their therapist. In essence, both are “action” therapies in which
clients do something about their difficulties, rather than just talk about them.
Furthermore, clients engage in specific tasks to alleviate their depressive symptoms.
These therapeutic tasks (i.e., homework assignments) are an integral part o f both BT
and CT and are commonly used to designate therapy procedures in the client’s natural
environment (Spiegler & Guevremont, 1998). In addition, the goals set for both
therapies are specific, as opposed to open-ended, and they guide the treatment process
that will be implemented for that particular therapy (Beck, 1970).
Another sim ilarity is the fact that both cognitive and behavior therapists focus
at least some o f their techniques at public, overt symptoms or behavior problems.
W hile the targets o f therapeutic change differ for both behavior and cognitive
therapists, both systems conceptualize symptom formation in terms o f constructs that
are accessible to either behavioral observation or to introspection (Beck, 1970).
Moreover, in contrast to psychoanalytic therapy, neither behavior nor
cognitive therapies focus their sessions on recollections or reconstructions o f the
client’s childhood experiences and early fam ily relationships. Causal relationships
12
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between childhood events and current psychological functioning are rarely made,
while the focus o f treatment is on the “here and now,” rather than on historical
determinants o f behavior. Techniques are employed to change the relevant current
factors that are influencing the depressive symptoms (Beck, 1970; Franks &
Barbrack, 1983; Spiegler & Guevremont, 1998).
A final commonality between behavior and cognitive therapies is that both
paradigms exclude most traditional psychoanalytic assumptions (e.g., infantile
sexuality, the unconscious, defense mechanisms, fixations) from clouding the
therapeutic process. More specifically, both systems essentially restrict the high-level
abstractions that are characteristic o f psychoanalytic therapy (Beck, 1970).
The Advent o f Cognitive-Behavioral Therapy

W hile the theoretical frameworks o f behavioral and cognitive therapies are
noticeably congruent on many levels, researchers have merged the two to form
“cognitive-behavioral” therapy (CBT) for depression (e.g., Beck’s Cognitive
Therapy). Essentially, CBT represents an extension o f traditional behavior therapy
and encompasses the modification o f cognitive events as actual behaviors (Kovacs,
1979). While behavioral and cognitive approaches differ in their emphasis on the
etiological role o f overt and. covert behaviors, when the two systems are united to
form the cognitive-behavioral approach, it is indicated that both covert and overt
behaviors play important roles in maintaining and modifying depression (Taylor &
Marshall, 1977).
13
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According to Dobson & Block: (1988), the actual outcomes o f CBT will vary
from client to client, but in general, the two m ain indices targeted for change are both
cognition and behavior. At its core, CBT shares three key positions: (1) cognitive
activity affects behavior, (2) cognitive activity may be monitored and altered, and (3)
desired behavior change may be affected through cognitive change (Dobson & Block,
1988). Both cognitive and behavioral techniques are exercised in CBT, as the
therapeutic goal is twofold. Therapist and client set out to alter faulty information
processing systems, while simultaneously modifying the environmental contingencies
that maintain depressive symptoms.
W hile CBT places emphasis on the cognitive mechanisms that create
behavioral effects, Dobson & Block (1988) add that elaborate cognitive mechanisms
are not ultimately required for behavioral change to occur. In fact, some CBT
interventions may have little to do with cognitive appraisals and evaluations, but may
instead be heavily dependent and focused upon client actions and behavior.

14
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CHAPTER II
REVIEW OF THE LITERATURE
Evidence Supporting Behavior Therapy

W hile CBT has been widely established as an effective treatment modality, its
components in isolation have also proven to be clinically effective. Numerous studies
have investigated depression treatments with an emphasis on behavioral principles
and interventions and have produced findings that support the use o f these techniques.
For instance, in a study conducted by Wilson, Goldin, & Charbonneau-Powis (1983),
a behavioral treatment for depression was found to be clearly superior to no
treatment. Twenty-five depressed, non-psychotic participants were randomly
assigned to either a behavior therapy or a waitlist condition. Behavior therapy was
implemented for eight weeks and included interventions such as activity schedules,
graded task assignments, daily self-monitoring o f mood, and social reinforcement for
attempted and completed activities and tasks. Measures o f depressive-related
symptomatology and treatment-related target areas were administered prior to
treatment, at mid-treatment, at the termination o f treatment, and at a 5-month followup. In comparison to the w aitlist condition, participants in the BT condition
significantly unproved on self-report and clinician rated measures such as the Beck
Depression Inventory (BDI; Beck, Ward, Mendelson, Mock, & Erbaugh, 1961), with

15
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F ( l , 22) = 55.04, p < 0.01, and the Hamilton Rating Scale for Depression (HRSD;
Hamilton, 1960), with F ( l , 22) = 20.04, p < 0.01. Additionally, treatment effects
were maintained at the 5-month follow-up [F (1,14) = 56.0, p < 0.01]. The results o f
this study provided support for the use o f short-term behavioral therapy for
depression (W ilson et al., 1983).
Another study that provided support for BT as a viable treatment for
depression was conducted by McLean, et al. (1980). The authors compared socialskills behavior therapy for couples to a “doctors choice” treatment for 20 depressed
outpatients. According to their findings, the group that received social-skills behavior
therapy demonstrated significant improvement in original target problems as
compared to a “doctor’s choice” o f treatment group. The “doctor’s choice” treatment
varied as a function o f the treating agency and involved diverse psychological
interventions (e.g., office consultations with a social worker) or pharmacological
interventions (e.g., antidepressant medication). Ten patients received an 8-week
behavioral treatment and 10 were returned to their referral sources (“doctor’s
choice”). Pretreatment assessment consisted o f self-ratings o f mood and the
construction o f a list o f five problematic target behaviors (e.g., decrease use o f
negative verbal interactions). Results showed that at the end o f treatment, the
behavioral treatment had a significant positive impact on the target behaviors (p <
0.001), whereas those in the comparison group did not (p < 0.23). Also, compared to
pretreatment levels o f depression, the experimental group showed a significant
decrease in depression levels (r= 4 .0 7 ,p < 0.001), as measured by the Depression
16
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Adjective Checklist (DACL; Lubin, 1965). The significant difference in depression
levels were also maintained at the time o f follow-up (f = 3.42, p < 0.01). This study
yielded further support for the effectiveness o f behavioral techniques in the
management o f depression.
Evidence Supporting Cognitive Therapy
Cognitive therapy has also proven itself efficacious in the literature as a potent
treatment for depression. For instance, Shaw (1977) demonstrated that Beck’s CT
was clearly superior to a no-treatment control group in decreasing depressive
symptomatology. The sample consisted o f 32 mildly to moderately depressed
persons who were treated at a university student health service. A group treatment
format was utilized over four weekly 2-hour sessions. Results indicated that the
cognitive modification group, as compared to the waitlist control group, demonstrated
a significantly greater decrease in self-report depressive symptomatology on the BDI
(t = 4.47, p < 0.01) and on clinical ratings o f the HRSD (t —2.79, p < 0.01). These
results provided favorable and supporting results for a cognitive treatment program
for depression.
In a study conducted by Rush, Beck, Kovacs, and Hollon (1977) CT was
again established as a promising treatment for depression, as 79.8% o f patients
showed marked improvement or complete remission o f symptoms. Nineteen
moderate to severely depressed outpatients received a maximum o f 20 sessions o f
CT, while 22 participants (also experiencing moderate to severe depression) received
17
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weekly 20-minute medication reviews and nonspecific supportive therapy. Both
psychological and pharmacological treatments (i.e., Tricyclics) were administered for
12 weeks and assessments included a variety o f self-rating scales including the Beck
Depression Inventory and independent clinical ratings such as the HRSD and the
Raskin Depression Scale (Raskin, Schulterbrandt, Reating, & McKeon, 1970).
Results showed that not only was CT associated with a significant decrease in
depressive symptomatology on the BDI [r (17) = 11.76, p < 0.001], but it resulted in
greater clinical improvement on the HRSD [/ (14) = 7.78, p < 0.001] and the Raskin
Depression Scale [t (13) = 9.50, p < 0.001]. Additionally, a one-way analysis o f
covariance for treatment effects unveiled cognitive therapy as significantly more
effective than pharmacotherapy in reducing depressive symptomatology, with F
(1,29) = 4.43, p < 0.05 (Kovacs, 1979; Rush et al., 1977).
Finally, in a meta-analysis conducted by Dobson (1989), an exhaustive review
o f 28 studies was completed to analyze the effect o f Beck’s CT on depressed clients.
The clinical efficacy o f CT was compared against a waitlist or no-treatment control,
pharmacotherapy, behavior therapy, and other various psychotherapies (e.g.,
psychoanalysis, interpersonal therapy). The results o f this meta-analysis showed that
CT was more effective than nothing at all, behavior therapy, and pharmacotherapy.
More specifically, the average CT client did better than 98% o f control subjects, 67%
better than behavior therapy clients, and 70% better than drug therapy o r other
psychotherapy clients.
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Evidence for Combined Treatment-Medication Plus Cognitive Therapy

As noted by Hollon, et al. (1992), numerous questions remain regarding the
efficacy o f CT relative to pharmacotherapy in the treatment o f depression.
Consequently, numerous studies have been conducted that examined the combined
effects o f CT and pharmacotherapy in comparison to each modality in isolation (for a
comprehensive review, see Hollon, Shelton, & Loosen, 1991). The literature seems
to be divided in that some studies favor the combined modality o f cognitive
pharmacology over either treatment alone (Bowers, 1990), while others have found
no significant differences between combined treatment and CT or pharmacotherapy
alone (Murphy, Simons, Wetzel, & Lustman, 1984; Hollon, Shelton, & Davis, 1993;
O ei& Y eoh, 1999).
A recent study reported a significant benefit for combined treatment in a
multicenter study o f patients suffering from chronic, nonpsychotic m ajor depression
(Keller, et al., 2000). The sample consisted o f 681 adult outpatients who were
randomly assigned to (a) cognitive-behavioral therapy, (b) nefazodone, or (c) a
combination o f the two. All treatments were administered for 12—16 weeks and the
primary outcome measure was the Hamilton Rating Scale for Depression (HRSD;
Hamilton, I960). Remission was defined a priori as an HRSD score o f no more than
8 at weeks 10 and 12. Although participants in all three groups significantly

improved over the 12 weeks (p < 0.001), an analysis o f endpoint HRSD scores
revealed that from week 4 through 12, the average rate o f improvement in the
combined-treatment group was significantly larger than the rate o f improvement in
19
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the nefazodone and psychotherapy groups ip < 0.001). More specifically, 85% o f
participants in the combined-treatment group had a positive response to treatment by
week 12, as compared with 55% o f participants in the nefazodone group and 52% in
the psychotherapy group ip < 0.001 for both comparisons). Because the combined
treatment group achieved early benefits from medication and then additive benefits
from psychotherapy later in the trial, the authors suggested that the combination o f
two independent effects rather than a synergistic mode o f action, increased patients
response to treatment. In sum, the authors determined that the degree o f superiority
o f combination therapy provided a clinically meaningful advantage over both CT and
medication alone.
One study that attested to the additive effects o f combined cognitive
pharmacotherapy was conducted by Blackburn, et al. (1981). Sixty-four clinically
depressed patients, drawn from a general practice setting and a hospital outpatient
clinic, were randomly assigned to 20 weeks o f treatment in one o f three conditions:
(a) cognitive therapy, (b) tricyclic pharmacotherapy, o r (c) a combination o f the two.
Depressive symptomatology was assessed via the BDI, HRSD, and the Snaith’s
Irritability, Depression, and Anxiety Scale (IDA; Snaith, Constantopoulos, Jardine, &
McGuffin, 1978). For the outcome results, Snaith’s scale displayed few overall
changes, but the BDI and HRSD both revealed clear cut effects. Results revealed that
in the hospital outpatient sample, the combined treatment o f CT and tricyclics was
significantly superior to CT or pharmacotherapy alone ip < 0.01). In the general
practice setting however, the combination treatment and CT alone were equally
20
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effective and considerably better than drugs alone (Blackburn et al., 1981), Not only
did this study have implications for establishing appropriate treatments for
depression, but it also was the first outcome study to use a population that was not
from North America. Previous to this study, the generalizability o f the effectiveness
o f CBT across continents was in question, but using a European sample served to
decrease existing suspicions (Williams, 1992).
In contrast, studies have not found any significant advantage for the combined
modality relative to either modality alone. Murphy et al. (1984) compared the
differential effects o f CT, pharmacotherapy, CT plus a placebo, and CT plus
pharmacotherapy by randomly assigning eighty-seven moderately to severely
depressed psychiatric outpatients to one o f four conditions. Each participant
completed 12 weeks o f treatment and was assessed with a self-report measure (i.e.,
the BDI) and an independent clinical interview (i.e., the HRSD). Results prompted
the authors to conclude that overtim e, while all three treatment groups led to
significant decreases in depressive symptomatology [F (2,65) = 236.50, p < 0.001],
improvement did not differ as a function o f the different treatment modalities [F (6 ,
130) = 0.32, p = 0.92]. In essence, combining treatments did not lead either to
additive effects or negative interactions (Murphy et al., 1984).
In a more recent randomized clinical trial, Blackburn & Moore (1997) also
found that combining CT and medication was not significantly more effective in
lowering depression levels than either treatment alone. Seventy-five outpatients with
recurrent m ajor depression were allocated to three groups, each including 16 weeks o f
21
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acute treatment and two years’ maintenance therapy, in the following manner: (a)
antidepressants and maintenance antidepressants, (b) CT and maintenance CT, or (c)
a combination o f antidepressants and maintenance CT. Ratings on outcome measures
(i.e., BDI-n and HRSD) were repeated every four weeks during acute treatment and
every four months during the 2-year follow-up phase. Results for acute treatment
showed that over the 16-week treatment period, all three treatment groups continued
to improve over time and there was no significant difference among treatments on
both the HRSD and the BDI-II (p < 0.0001 for both measures). Results o f longer
term outcomes indicated that patients in all groups continued to improve significantly
over time [F (6,329) = 4.51, p < 0.001] and there were no significant differences
between treatments [F(2,55) = 0.31,/? = ns] at any point in time. Thus, this result
supported the idea that combining acute medication and maintenance CT treatments
was not more effective in lowering depression levels than either treatment modality
alone. Further analyses did show one trend for a difference appearing at 20 months
on the BDI [ F (12,329) = 1.61,/? < 0.08], reflecting a more steady improvement in
the two maintenance CT groups. This allowed Blackburn and Moore (1997) to
conclude that “maintenance cognitive therapy has a sim ilar prophylactic effect to
maintenance medication and is a viable option for maintenance after acute treatment
with medication in recurrent depression” (p. 328).
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Combined Cognitive and Behavior Therapy
Not only have the behavioral and cognitive therapies been tested for clinical
efficacy, but a variety o f studies have also supported cognitive-behavioral treatments
for depression. One such study (Taylor and Marshall, 1977) noted that, because both
covert and overt events play important roles in maintaining and modifying
depression, the additive effects o f behavior and cognitive therapies (i.e., CBT) may be
therapeutically more effective in decreasing depressive symptomatology than either
modality alone. The authors tested this hypothesis by randomly assigning 28 mild to
moderately depressed college student volunteers to one o f four groups: ( 1) cognitive
treatment, (2) behavior treatment, (3) cognitive and behavioral treatments combined,
or (4) waitlist control group. Behavior therapy encompassed the approaches o f
Ferster, Lazarus, and Lewinsohn, while CT encompassed a combination o f modalities
offered by Beck, Ellis, Bandura, and Marston (Kovacs, 1979). Each experimental
participant received six 40-minute treatment sessions. Depression outcome measures
included the BDI, the D-30 scale (Dempsey, 1964), and the Visual Analogue Scale
(VAS; Aitken, 1969). Results showed that while there were significant
improvements in self-rated symptomatology for all three treatment groups, the
combined cognitive-behavioral treatment was more effective in decreasing depressive
symptoms [F (1,18) = 6.71 ,p < 0.03) than either behavioral o r cognitive treatments
alone. These effects were maintained at the 5-week follow-up point [ F ( 1 ,18) = 9.64,
p < 0.01]. In their attempt to examine the utility o f CBT, Taylor and Marshall (1977)
23
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concluded that for maximum benefit, the integration o f BT and CT (i.e., CBT) should
be performed when treating depression.

Dismantling o f Cognitive Behavior Treatment
W hile the clinical effectiveness o f CBT has been well-documented (Dobson,
1989; M iller & Berman, 1983; Taylor & Marshall, 1977; Williams, 1992), a question
remains as to which component o f CBT is most responsible for therapeutic change
and improvement. Is it the behavioral component, the cognitive component, or the
additive effects o f the two that make CBT so clinically effective? There is an evident
need to dismantle CBT in order to identify the components that are either sufficient or
vital ingredients for improving depressive symptomatology.
An ingenious study conducted by Jacobson, Traux, Addis, Koemer, GoIIan,
Gortner, & Prince (1996) set out to answer these questions by dissecting Beck’s CT
for depression (Beck et al., 1979). Jacobson and his colleagues randomly assigned
152 depressed outpatients to one o f three treatments based on components o f CBT:
(1) behavioral activation (BA), which is the behavioral component o f CBT; (2)
automatic thoughts (AT), which includes behavioral activation along w ith skills to
modify automatic thoughts or; (3) “full” CBT, which consists o f behavioral
activation, modification o f negative thoughts, plus changing core dysfunctional
schemas. It was hypothesized that “CT should work significantly better than AT,
which in turn, should work significantly better than BA” (p. 296). An additional
purpose for this study was to investigate whether the various treatments differentially
24
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affected the process that they were supposed to affect. For instance, was the “full”
CBT more successful at modifying dysfunctional schemas than BA? Would the BA
condition be more successful at activating people to participate in previously
enjoyable activities than the full CBT?
Participants in each condition received treatment for 16 weeks with a
maximum o f 24 sessions. The depressive symptomatology was measured for all
participants with the Longitudinal Interval Follow-up Evaluation-II (LIFE; Keller, et
al., 1987), the BDI and the HRSD. Measurements were taken before therapy, at the
time o f termination, and at 6 ,1 2 , and 24-month follow-ups. Unexpectedly, results
showed that after 20 sessions, as well as at the 6 -month follow-up, there were no
significant differences in self-reported depression levels between the three groups.
Additionally, there were no differences found between the treatments one or two
years after treatment (Gortner, Gollan, Jacobson, & Dobson, 1998).
In opposition to their hypothesis, those who received BA alone fared as well
as those who were taught additional coping skills to counter depressive thinking.
Essentially, the BA component was as successful in reducing depression and altering
negative thinking and attributional styles as was the AT and “full” CBT conditions.
M ost importantly, this study identified the BA condition as an active ingredient in
CBT, capable o f producing clinically significant antidepressant effects. In sum,
Jacobson and his colleagues found no evidence that CBT was any more effective than
either o f its components alone (Jacobson et al., 1996). In other words, as noted by
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Martell, Addis, & Jacobson (2001), helping to activate these participants was just as
effective to treat their depression as helping them to change their thinking.
These results have important implications for the treatment outcome o f major
depression, as they run contrary to the cognitive model o f depression put forth by
Beck and his colleagues (Beck et al., 1979), that states that the modification o f
negative cognitions are necessary to maximize treatment outcome. The Jacobson et
al. (1996) study calls into question some o f the assumptions o f the cognitivebehavioral model by suggesting that altering thinking and dysfunctional schemas may
not be necessary to counter depressive symptomatology. Alternatively, it is
suggested that the participation in and exposure to a variety o f pleasurable activities
served not only to change dysfunctional thinking, but to act as an antidote for
depression (Hammen, 1997).
In the search for empirically validated treatments that are short-term, costeffective and simpler to leam and administer, the Jacobson et al. (1996) findings may
have great economic and clinical value. Having to implement only the BA portion o f
CBT makes behavioral activation appear much more parsimonious and “user
friendly” (Robinson et al., 1996). As noted by Chambless and Hollon (1998), the
behavioral approaches to depression are typically easier to m aster than the more
complex cognitive interventions. In turn, this could make BA more accessible to less
experienced orparaprofessional therapists. Furthermore, BA represents a less
expensive alternative to CBT in that the intervention choices are fewer and therapists
do not have to implement the foil CBT treatment plan (Jacobson et al., 1996).
26

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

Problem Statement
Previous research suggests that cognitive behavioral treatment o f depression
stands as the psychotherapeutic intervention o f choice in the treatment o f clinical
depression (Hammen, 1997). Recent work by Jacobson et al. (1996) further suggests
that the active ingredient in cognitive behavioral treatment o f depression m ight entail
behavioral activation. This ingredient is found in the overall cognitive behavioral
treatment protocol as one o f three clearly identifiable components. According to the
Jacobson investigation behavioral activation may be simpler to administer and yet
achieve outcomes that equal those found with the full cognitive behavioral treatment
protocol. If this observation can be verified it would serve to render a more efficient
treatment for clinical depression. It would also give rise to a conceptual challenge to
the prevailing theory o f cognitive behavioral intervention; a theory that suggests that
direct modification o f dysfunctional cognitions is essential for successful treatment
outcome.
The present investigation aims to conduct a quasi-replication o f the basic
findings noted in the Jacobson study. It will utilize a sample that differs, however,
from that treated by Jacobson. In the practice setting in which most psychologists
operate, clients present for treatment even while still consuming psychotropic
medications. O f all the people who are prescribed a psychotropic medication by a
psychiatrist, as many as one-quarter to one third (30.4%) are treated with
antidepressant medication (Olfson & Klerman, 1993). It is policy in many
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community agencies that clients who are diagnosed as clinically depressed and who
receive antidepressant medication must also be seen by an additional psychosocial
intervention service. These other psychosocial interventions may include
psychotherapy, case management, orpsychoeducational services (personal
communication 1998, Venture Behavioral Health).
Because o f this prevailing reality, it is important to test the effectiveness o f
behavioral activation w ith clients who realistically present while consuming
medication, in addition to testing clients who are unmedicated, as was done in the
Jacobson study. Yet this must be done in a way that allows for reasonably valid
comparisons between persons who were and were not medicated. This arrangement
is made difficult in the present study by the absence o f a psychiatrist who would
simultaneously administer medication or no medication within the context o f the
proposed research design. However, the present investigation will attempt to achieve
quasi-experimental control that permits reasonable inferences regarding the effects o f
behavioral activation treatment o f both samples. The primary research question is
“W hat are the effects o f behavioral activation on a mixed sample o f medicated and
unmedicated depressed adults?” hi answering this question, this study will provide
further clarification on the role o f behavioral activation protocol in the treatment o f a
more “real world” sample o f depressed clients.
In this investigation, rather than random assignment to one or the other
medication condition, all subjects, irrespective o f medication condition will be
randomly assigned to either a w aitlist (delayed treatment) control or an. immediate
28
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treatment condition. Those subjects who are medicated, however, will have to have
initiated medication at least four weeks prior to entering the study and m ust remain on
the same medication for the duration o f the study period. Changes in doses will be
allowed. This arrangement is essential in order to provide a fair test o f whether any
treatment outcomes are attributable to the medication condition alone. If subjects in
the delayed treatment condition continue to qualify for admission into the study even
though they continue to take medications for a period o f at least six weeks, then it is
unlikely that observed treatment outcomes can be easily attributable to medications
alone. This would suggest that behavioral activation was at least a contributing factor
to treatment outcome.
On the other hand, i f unmedicated subjects who receive immediate treatment
demonstrate positive outcomes at post-treatment, when compared to the unmedicated
subjects in the delayed treatment condition, then it m ust be concluded that behavioral
activation was likely responsible for the observed outcomes. However, because o f
the quasi-experimental nature o f this investigation, no firm conclusions regarding
causality can be drawn. That level o f conclusion will be left to a future true
randomized controlled trial.
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CHAPTER III

METHOD
Sample
Seventeen adult participants seeking mental health services for Unipolar
Depression were recruited from the Kalamazoo and Southwestern Michigan regions
through public service announcements, newspaper advertisement, solicitations from
community professionals, and other healthcare agencies.
All participants met criteria for Major Depressive Disorder (MDD) according
to the Diagnostic and Statistical Manual o f Mental Disorders (4th edition; DSM-IV;
American Psychiatric Association, 1994). The DSM-IV diagnosis was based on the
Structured Clinical Interview forDSM -IV-Non Patient (SCID-NP; First, Spitzer,
Gibon, & Williams, 1997). Participants scored at least 20 on the Beck Depression
Inventory-II (BDI-H; Beck, Steer, & Brown, 1996), and 14 or greater on the Revised
Hamilton Rating Scale for Depression (RHRSD; Warren, 1996). The author and a
licensed clinical psychologist who had utilized both outcomes in several other
investigations provided training and supervision o f the RHRSD and SCID-NP.
Exclusion criteria included a number o f coexistent psychiatric disorders
including bipolar o r psychotic subtypes o f depression, panic disorder, current alcohol
or other substance abuse, past o r present schizophrenia o r schizophreniform disorder,
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organic brain syndrome, obsessive compulsive disorder and mental retardation.
Additionally, the comorbid presence o f personality disorders were limited inasmuch
as the percentage o f patients with a personality disorder in the sample approximated
the percentage o f patients in the population o f Psychology Clinic patients having the
same personality disorder.
Furthermore, suicidality was assessed and participants who presented a
considerable risk were referred for service outside o f the study for further assessment
and determination o f appropriateness for participation in the study. A licensed
clinical psychologist, along with the author, made final decisions regarding the
eligibility o f the participants. Suicide risk was determined by an individual’s
responses to the suicide items on the BDI-II, the RHRSD, and the SCID-NP, as well
as by any verbalizations o f suicidal ideations made by the patient during the
assessment phase o f the study. Finally, participants who were in some concurrent
form o f psychotherapy or who needed to be hospitalized because o f imminent suicide
potential o r psychosis were deemed ineligible for the study and referred for
alternative treatment.
Setting
All assessment and treatment sessions were conducted in private therapy
rooms at Western Michigan University’s Psychology Clinic, located at 1000 Oakland
Drive, Kalamazoo, MI. Each room was equipped with a one-way m irror so that the
integrity o f the treatment could be monitored with video cameras.
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Assessors and Therapists
Second and third year doctoral students in a clinical or counseling psychology
graduate program conducted all assessment interviews. Training and supervision o f
the assessment tools were provided by the author and included SCID training videos
and the BDI-II and RHRSD manuals.
Therapists were selected and trained from among third year doctoral students
in clinical and counseling psychology graduate programs. All therapists had at least
two years practicum experience. Therapists received basic training in the cognitive
behavioral treatment o f depression and for purposes o f the present investigation
received an additional 12 hours o f training in the use o f Behavioral Activation (BA)
therapy. All therapy training was conducted by the principal investigator, Richard
Spates, Ph.D., who is a licensed clinical psychologist and has vast experience in
cognitive behavioral therapy, along with the author, who at the tim e o f training had
three years practicum experience and held a temporary license to practice in the state
o f Michigan.
Treatments
The treatment implemented in this study was the “behavioral activation”
component o f Beck’s Cognitive Therapy (CT; Beck et al., 1979). Behavioral
Activation therapy is based on the behavioral conceptualization that depression is best
understood as “a series o f actions and events rather than some sort o f internal object
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or mechanism” (Martell et al., 2001, p. 12) and results from changes in client’s life
circumstances (e.g., death o f significant other, losing a job). The loss o f
reinforcement resulting from these life changes is what precipitates the depression.
Once an individual is depressed, the negative way in which he or she responds to their
environment (e.g., avoidance) often exacerbates their dysphoric mood by depriving
them o f further reinforcement. Thus the purpose o f BA is to activate clients so that
they may break a passive approach to life and maximize their opportunity to make
contact with natural, positive reinforcers in their environment (Martell et al., 2001).
The emphasis o f BA is on “focused activation,” as opposed to simply activity at
random. This includes not only finding behaviors and activities that will be positively
reinforcing, but paying close attention to the activities with which one is participating
(e.g., noticing colors, noises, and smells associated with the activity). This attention
to the experience intervention is very similar to the mindfulness training taught by
Marsha Linehan in Dialectical Behavior Therapy (Jacobson, Martell, & Dimidjian,
2001; Linehan, 1993).
Behavioral Activation treatment is a therapeutic tool whose goals are to (a)
determine the life circumstances that precipitate the depression, (b) determine the
coping patterns that m aintain and exacerbate the depression (e.g., chronic negativity,
social withdrawal), and (c) develop a treatment plan for improving the coping
patterns and provide access to m ore reinforcing life circumstances (Jacobson, et al.,
1997). The BA therapist helps the client to achieve these goals by working w ith them
as a so-called “personal trainer” who helps them to learn and implement a set o f skills
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that are likely to be effective, ju st as a supportive coach might do. The therapy is
delivered in a directive manner, but the client and therapist choose the direction in
concert. It is important to note that the therapist coaches the client to learn a core set
o f BA skills, but because the skills’ form varies from client to client, the BA therapist
is required to be flexible, proficient, and able to coach a wide range o f unique clients.
Without such a supportive, collaborative working relationship, it is unlikely clients
will change ingrained patterns o f maladaptive behavior (Martell et al., 2001) and meet
the BA treatment goals.
What BA is not about is teaching clients simple maneuvers that increase
pleasant activities. Many people engage in regular, positive activity and are still
depressed. Therefore, pleasant events in and o f themselves cannot be assumed as
antidepressants (Dobson & Joflfe, 1986). As noted by Martell et al. (2001), BA is not
about getting people to do nice or fun things. It is about incorporating directed
activity into a client’s narrow repertoire o f behavior, regardless o f how one feels
internally, so that they break avoidance patterns and increase the possibility o f
coming in contact with reinforcers in their environment.
Behavioral Activation is also not a “psychotherapy from the neck down”
(Martell et al., 2001, p. 64). Therapists who treat clients with BA recognize that not
only are inactivity, withdrawal, and avoidance commonplace depressive behaviors,
but according to Nolen-Hoeksema, Morrow, & Fredrickson (1993), a great deal o f
tim e is also spent thinking about, or ruminating, the m isery o f their lives. Thus the
context o f client thinking is assessed and acknowledged, rather than the actual content
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o f the thought. For instance, if a client presents w ith the ruminative thought,
“everyone at school hates me,” the BA therapist would ask the client under what
conditions does this sort o f thinking occur, what is he doing when thinking that way,
and what is he avoiding by spending time ruminating? The client is then encouraged
to identify antecedents and consequences o f such ruminations. Moreover, the
veracity o f that thought would not be challenged or evaluated, but rather the impact o f
the behavior “thinking that people hate me” would be addressed (Martell et al., 2001).
The theory and practice o f BA is based primarily upon a manual called
Cognitive & Behavioral Treatment o f Depression: A Research Treatment Manual,
developed by Jacobson and colleagues (Jacobson et al., 1997). This training manual
was derived from Beck’s original cognitive therapy manual, called Cognitive Therapy
o f Depression (Beck, et al., 1979). The BA treatment manual used in this study
contains a total o f 25 prescribed assessment and intervention techniques that
therapists can use with their clients. Specific assessment techniques include, but are
not limited to, conducting functional analyses, symptom reports from the BDI-II, and
daily activity schedules. Specific intervention techniques that BA therapists are
permitted to use include, but are not limited to, assigning activities to increase a sense
o f mastery or pleasure, graded task assignments, examining alternative behaviors in
different situations, therapist modeling o f activation strategies, and teaching clients to
give themselves rewards for behavioral achievements. The manual also lists those
interventions that should not be included in treatment (i.e., cognitive interventions).

35

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

Ia sum, over the course o f treatment, therapists administering BA teach clients
a series o f interventions that not only help determine the life circumstances that may
have precipitated the depression, but also identify the coping patterns that most likely
exacerbated the depression. Ultimately the therapist helps the client decrease
avoidance behaviors that maintain the disorder, while teaching the client new coping
patterns that provide access to more rewarding life circumstances.

Treatment Integrity
In order to insure that BA was administered properly, protocol outlines were
supplied to each therapist for each session after initial training. These outlines
described essential steps in the procedure. The particular treatment adherence
measure used in this study (Appendix A) was a modified version o f the National
Institute o f Mental Health Collaborative Study Psychotherapy Rating Scale (CSPRS;
Hollon, Evans, Elkin, & Lowery, 1984) that included the procedural steps in BA,
along with a checklist o f prescribed BA techniques. Also included was a list o f
proscribed cognitive therapy techniques.
Trained observers then viewed a random sample o f the video taped treatment
sessions ( 11%), checking off the presence o f each step in the outline, along with the
specific treatment interventions used that session. Furthermore, inter-rater reliability
checks were performed on this same sample o f videotapes. It is also important to
note that the therapists participation in ongoing research team meetings specific to
this investigation likely reduced therapist d rift
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Outcome Measures
Depression levels were evaluated for each participant before treatment began,
weekly during the course o f treatment, at the termination o f treatment, and at three
months following the cessation o f treatment. The BDI-II (Beck et al., 1996), the
RHRSD (Warren, 1996) and the SCID-NP (First et al., 1997) were the three
inventories used to measure depression levels in all participants. The BDI-II was
completed at the intake session for both the waitlist and treatment conditions. Those
in the waitlist condition only were assessed with the BDI-H at the beginning, middle,
and end (i.e., every other week) o f their six-week delay period. Once the wait period
ended, participants in both conditions completed the BDI-II at the same weekly
intervals over the course o f treatment to monitor weekly changes in symptom
severity. Participants in the treatm ent and waitlist conditions were also given the
BDI-H at post-test and at the 3-month follow-up. In order to assess for the presence
o f Major Depressive Disorder, the SCID-NP was administered at pretest, post-test,
and at the 3-month follow-up for both the treatment and waitlist conditions, while the
RHRSD was completed by the therapist at those same points for both groups.
Known as one o f the m ost widely used instruments to assess for depression,
the Beck Depression Inventory (BDI; Beck et al., 1961) focuses on evaluation in both
psychiatric and nonpsychiatric populations (Beck, Steer, & Garbin, 1988). According
to Beck, et al. (1961), the BDI was derived from clinical observations about attitudes
and symptoms displayed frequently by depressed psychiatric patients and
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infrequently by nondepressed psychiatric patients, hi order to correspond more
closely with the diagnostic criteria for m ajor depression in the DSM-IV, the BDI has
been upgraded to the BDI-H (Steer, Ball, Ranieri, & Beck, 1997). Not unlike the
original BDI, the BDI-II contains 21 items that measure 21 symptoms o f depression.
A four-point Likert-type scale, ranging from 0 to 3 is utilized for each item. The
BDI-II measures depressive symptomatology during the two preceding weeks, unlike
the original BDI that measured symptoms for the previous week only. Sum m ing the
ratings for the 21 items scores the BDI-II. The final score can then be converted to a
depression rating and the guidelines for such ratings are as follows: 0-13, minimal
depression; 14-19, mild depression; 20-28, moderate depression; 29-63, severe
depression.
The BDI-H has demonstrated clinical utility and reliable psychometric
characteristics across a broad spectrum o f both clinical and nonclinical populations
(Beck et al., 1996). According to Beck et al. (1996), the BDI-II had an alpha
reliability coefficient o f 0.92 when administered to a sample o f 500 outpatients from
four different psychiatric clinics. Beck et al. (1996) also confirmed the test-retest
reliability by administering the BDI-H to 26 outpatients. Participants completed the
BDI-H before their first therapy session and a week later, before their second therapy
session. Similar results were reported for both administrations ( r = 0.93, p < 0.001).
To provide construct validity for the BDI-II, Steer et al. (1997) administered
both the BDI-II and the Symptom CheckIist-90-R (SCL-90-R), an inventory often
employed for assessing self-reported depression and anxiety (Derogotis, 1983) to 210
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adult outpatients being evaluated for psychiatric problems. The results confirmed the
construct validity o f the BDI-H as the self-ratings on the BDI-II were more positively
correlated with the scores on the Depression subscale than they were with the scores
on the Anxiety subscale o f the SCL-90-R (Hotelling T207 = 8.40, p < 0.001). In the
same study, the internal consistency for the BDI-II was also established as the mean
total score on the BDI-H was 24.4 (SD = 13.3) and the coefficient alpha was 0.92.
According to Steer et al. (1997), this represents high internal consistency, as the
sample was moderately depressed according to the diagnostic ranges presented by
Beck et al. (1996). Finally, in order to attest to the convergent validity o f the BDI-II,
Beck et al. (1996) compared the BDI-II to the HRSD (Hamilton, 1960) and also to the
Hamilton Rating Scale for Anxiety (HARS; Hamilton, 1959). Findings presented the
BDI-H as more positively correlated with the HRSD ( r = 0.71) than with the HARS (r
= 0.47).
Developed in the late 1950’s, the HDRS is a widely used standardized
interview to measure the index o f severity o f depressive symptoms. Because the
HDRS is not intended to be a diagnostic measure, it is best completed following a
clinical interview. There have been two modifications to the HSRD since the original
version and it is now referred to as the Revised Hamilton Rating Scale for Depression
(RHRSD; Katz, Shaw, Vallis, and Kaiser, 1995). The revised version o f the HDRS
now consists o f 22 items and contains descriptive anchor points for each o f the values
for each item. Furthermore, “cognitive” items assessing hopelessness, helplessness,
and worthlessness have been added. These items serve only as descriptors and are
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not included in the total score for severity. O f the 17 scorable items, nine are rated on
5-point scales (0-4), and 8 on 3-point scales (0-2). Total scores range from 0 to 52.
Scores on the RHRSD o f 6 or below are considered to reflect normal, nondepressed
functioning levels; scores o f 7—17 are considered to reflect mild depression; scores o f
18-24 reflect moderate depression; and scores o f 25 or more are considered to reflect
severe depression (Katz etal., 1995).
As slight modifications were made to the HRSD to develop the RHRSD, the
strong psychometric properties o f the former were not compromised (Katz et al.,
1995). Thus the reliability and validity coefficients for the HRSD will be reported.
In a study conducted to test the reliability and validity o f the HRSD (Riskind, Beck,
Brown, & Steer, 1987), 120 psychiatric outpatients were administered both the HRSD
and the HARS. Results indicated the Chronbach alpha coefficient for the HRSD to
be 0.73, while the average item-total correlation was 0.47, indicating satisfactory
internal consistency (Riskind et al., 1987). As noted by Katz et al. (1995), data on the
interrater reliability o f the HRSD are impressive. In a study conducted by Hedlung
and Vteweg (1979), a systematic search was executed to locate all available research
reported on the HRSD from 1967 to 1979. O f the nine studies reviewed, the
interrater reliability coefficient was 0.84 or above. In addition, Ziegler, Meyer,
Rosen, & Biggs (1978) examined the interrater reliability o f the HRSD. Ratings were
made from a videotape o f an interview conducted by psychiatric residents and
compared to the actual interview ratings made by experienced psychologists.
Videotaped ratings correlated 0.97 with the actual interview ratings.
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The final inventory utilized in this study was the SCID-NP (First et al., 1997).
This is a semi-structured interview adminisered by a trained clinician that assesses 33
o f the more frequently diagnosed DSM-IV disorders in adults. The SCID-NP is
designed for use in studies in which participants are not identified as psychiatric
patients, such as family studies and research conducted in medical settings (Spitzer et
al., 1992).
The basic structure o f the SCID-NP interview is as follows. First, basic
demographic information is obtained. This is followed by questions that elicit the
primary complaint, history o f present and past periods o f psychiatric disturbance, and
treatment history. To end the interview, the clinician asks general questions about
current functioning, including mood, physical health, use o f medications, and social
functioning. A decision tree approach is utilized to test the clinician’s diagnostic
hypotheses (Spitzer et al., 1992).
The SCID-NP was initially used in this investigation at intake to select the
study population o f interest and ensure that all participants met the conditions that
were necessary for a DSM-IV diagnosis o f m ajor depression. Furthermore, it ensured
that participants did not m eet certain DSM-IV diagnoses that would deem them
ineligible for the study. The SCID-NP was then employed at post-test and at the 3month follow-up for both conditions to assess for major DSM-IV diagnoses and
documentation o f those criteria that were met.
The psychometric data on the SCID confirms it to be a reliable structured
interview. In a large-scale study using 592 participants (Williams et al., 1992), the
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test-retest reliability o f the SCID was examined. This study included randomly
matched pairs o f two professionals who independently evaluated and rated the same
subject within a 2-week period. Combining all disorders on the SCID yielded a
weighted Kappa o f 0.61 for current disorders and 0.68 for lifetime disorders.
According to Williams et al. (1992), these values are comparable to those obtained
with other structured diagnostic instruments.
W hile the reliability o f the SCID has been empirically established in
numerous studies (Segal, Hersen, & Van Hasselt, 1994), there has been little effort to
evaluate its validity (Malgady, Rogler, & Tyron, 1992). In fact, as noted by Kranzler
et al. (1996), prior to the execution o f their validity study on the SCID, they found no
published reports assessing the validity o f the SCID. To validate SCID diagnoses,
Kranzler et al. (1996) divided a sample o f 100 substance abuse patients into
subgroups based on the presence o r absence o f SCID diagnoses o f different substance
use disorders and comorbid conditions. These subgroups were compared on scores
from interviews and questionnaires administered at the time o f treatment and six
months after discharge from treatment.
The authors first found support for the concurrent validity o f the alcohol
abuse/dependence diagnosis when, as expected, those patients diagnosed with the
disorder had a more extensive family history o f alcoholism compared with patients
who had never m et criteria for alcoholism (F = 1 0 .7 ,< 0.001). Excellent
discriminant validity for both current (F = 29.14, p < 0.001) and lifetim e (F = 22.43,
p < 0.001) alcohol and drug abuse/dependence was also established for this sample.
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As predicted, alcohol-related problems were less prevalent in drug-dependent patients
who were not also alcoholic. Additionally, fewer drug-related problems were exuded
in alcoholic patients who were also not drug dependent (Kranzler et al., 1996).

Procedure
Adult participants seeking mental health services for major depression were
recruited for this study. Recruitment materials included the use o f newspaper
advertisements, public service announcements, public postings, and solicitation from
community professionals and other healthcare agencies.
Interested individuals contacted the Anxiety Disorders research group’s
telephone line and left a message requesting to participate in the study. All those
interested were called back and an initial telephone screening was conducted
(Appendix B). During this screening, the nature o f the study was explained and
individuals were assessed for depression symptoms. In addition, individuals were
asked if they were currently using any psychotropic medication or currently enrolled
and participating in psychotherapy o f any sort. People who were not experiencing
symptoms o f depression, who had been taking prescription medication for their
depression for less than six weeks, and/or who were currently in other psychological
treatments were deemed ineligible for participation. Appropriate referrals for mental
health services were offered to all ineligible callers.
Eligible individuals were then invited to participate in a second
intake/assessment session held at the Psychology Clinic. Prior to the completion o f
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any outcome measures, individuals were presented with two consent forms
(Appendix C) explaining the nature o f the study and guaranteeing their
confidentiality. Answers to any questions regarding the study were then provided.
Individuals were then asked to sign the consent forms indicating their approval for
participation. One consent form was returned to the assessor while the individual
kept the second for their records.
The next step o f this intake involved individuals’ completing a brief
demographic questionnaire (Appendix D). The BDI-II (Appendix E) was then
completed and if a score o f at least 20 was obtained, individuals were subsequently
interviewed with the SCID-NP (available upon request). If a diagnosis o f major
depression was obtained and other disorders that would deem a person ineligible were
ruled out, individuals were thanked for their time and told they would be notified
within one week regarding their eligibility in the study. Finally, assessors completed
the RHRSD (Appendix F) and if a score o f at least 14 was obtained, this person was
deemed eligible and allowed to progress to the next step o f the study.
Eligible individuals were then telephoned within one week and invited to
participate in the study. If they chose to participate, each person was assigned a
research code number to be used on all subsequent forms and randomly assigned into
an immediate treatment or waitlist control condition. Participants in the immediate
condition were scheduled for their first appointment to begin treatment.
Alternatively, those in the waitlist condition were told they would first participate in
an “assessment phase” for which information about their depression would be
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gathered in advance to starting therapy. These participants then came into the clinic
every other week, for a total o f three visits, while on the 6-week waitlist. During this
visit, participants simply filled out the BDI-II and a subsequent appointment was
scheduled. If the participant scored at least a 20 on the BDI-H at the end o f six
weeks, they were scheduled for their first appointment to begin treatment.
Participants in both the immediate and delayed treatment conditions
underwent 10 one-hour sessions o f BA on a weekly basis. The treatment o f BA was
delivered in a standardized manner by a therapist at the Psychology Clinic, whose
role was, as mentioned previously, very sim ilar to that o f a “personal trainer.” A t the
very beginning o f treatment, therapists clarified that their job was to help clients
identify what was wrong in their lives and guide them in finding activities and
behaviors that provide them with the pleasure and interest that was absent from their
lives. This rationale was delivered w ith optimism, as clients were encouraged to
consider changes in their behavior that would in turn lessen their depression
(Jacobson et al., 1997).
Each BA treatm ent session involved a distinctive beginning, middle, and end.
The beginning o f each session included greeting the client and asking them to
complete the BDI-II. Issues that would be covered throughout the rest o f the session
were then placed on an agenda as the therapist and client worked collaboratively to
determine the m ost important topics for that week. Next, the BDI-II was reviewed,
paying close attention to the specific questions that target suicidal behavior and
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weekly activity levels. Any homework assignments the client completed between
sessions were also discussed.
About 10 minutes into the session, the client and therapist progressed to the
middle o f the session where they worked jointly on the previously set agenda items.
The therapist typically did not stray from the prescribed agenda unless an
extraordinary issue arose (e.g., suicidality). Essentially, the middle part o f the session
was used to work on the issues o f importance.
As the session came to a close, the therapist briefly reviewed the topics that
were covered and assigned a between-session assignment in relation to what was
discussed that day. It was the therapist’s responsibility to make sure the homework
was well understood by the client and that it would be completed. As treatment
progressed, the client began to assume responsibility for reviewing the session and
assigning homework to him or herself. Finally, the client was given the opportunity
to comment on that days’ session and a date was set for the next session.
After 10 weeks o f treatment, each participant returned to the clinic the
following week for a post-test session. Each participant met w ith a clinical assessor
who administered the BDI-II and the SCID-NP. Finally, the assessor independently
completed the RHRSD.
Next, telephone calls were made to schedule a three-month follow-up
appointment. During this visit, participants completed the BDI-H and were
interviewed with the SCID-NP. Again, the assessor independently completed the
RHRSD. At this time, assessment was complete and participants’ involvement in the
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study was concluded. Research folders were then closed and transferred to the
Department o f Psychology at W estern Michigan University where they w ill remain in
a locked cabinet for at least three years. They will then be destroyed.
Finally, the research data for each participant was kept in personal folders in a
locked filing system established at the Psychology Clinic. Maintaining these filing
systems and participant folders was the responsibility o f the researcher. A master list
(Appendix G), used to ensure the confidentiality o f the research data, was the only
link between participants and their research code numbers. Additionally, a universal
data collection form (Appendix H) was used to record all assessment information for
each participant. Progress notes and other clinic related treatment documentation for
each participant were kept separate from the research data and was managed by the
Psychology Clinic.
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CHAPTER IV

RESULTS
Analysis Plan

For this investigation, it was hypothesized that depressive symptoms would
decrease for individuals in the immediate and w aitlist comparison groups only after
treatment had been administered to each group (see Figure 1). Principal measures
included outcome ratings on the Beck Depression Inventory-II and Revised Hamilton
Rating Scale for Depression.
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Figure 1. Projected Therapeutic Gains on the BDI-H for the Total Sample, by
Condition.
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In order to test this hypothesis, this study incorporated a pretest/post-test
waitlist comparison group and included a 2 X 3 repeated-measures design. Two
levels o f the between-group factor included the waitlist and immediate treatment
conditions. Three levels o f the within-group factor consisted o f assessment time
(pretest, post-test, and follow-up). All participants were randomly assigned into an
immediate treatment or waitlist control condition. A planned comparison between
individuals receiving immediate treatment versus those assigned to a 6-week waitlist
was expected to demonstrate whether the treatment was effective. Likewise, it was
expected that waitlist-assigned individuals would demonstrate symptom reduction
only after they had received the BA intervention. The within-group comparisons
were expected to reveal change for subjects from pretest to post-test for both
conditions, with a stable symptom pattern for the waitlist-assigned individuals during
their pretreatment phase.
Analyses were computed for all participants who fulfilled minimum
requirements o f their assigned condition. For both groups, data were included in the
analysis if participants completed a minimum o f six sessions o f BA. The first
primary analysis o f the study consisted o f a repeated-measures analyses o f variance
(ANOVA) that examined outcome measures across time for participants in both
groups who completed BA. Given the significant omnibus F-tests, follow-up paired
f-tests were computed separately for each dependent variable and time course. More
specifically, for the immediate treatm ent condition, differences on each dependent
measure were examined between (a) pretest and post-test, (b) pretest and 3-month
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follow-up, and (c) post-test and 3-month follow-up. For the waitlist condition,
differences on dependent measures were examined at those same assessment points,
but also between (d) the beginning and end o f the waitlist assessment.
In order to detect differences in depression levels between the immediate
treatment and waitlist condition, further comparisons were made at (a) pretest, (b)
post-test, and (c) 3-month follow-up. Independent samples r-tests were performed at
those time periods with BDI-II and RHRSD scores as dependent variables.
So as to maximize the number o f total participants entered into the analyses,
and therefore increase the power o f the study, the immediate and waitlist group data
were thereupon combined and assessed for change over time. Repeated-measures
ANOVA’S were performed on the collapsed group. Planned within-group
comparisons in mean BDI-II and RHRSD scores for this total sample were then
examined between (a) pretest and post-test, (b) pretest and 3-month follow-up, and (c)
post-test and 3-month follow-up. In a subsequent ‘missing data’ analysis, post-test
scores for each participant were carried forward to substitute for the missing followup data where necessary. These analyses were also conducted using multiple
repeated-measures ANOVAS, along with within-subject contrasts to detect exactly
where the differences between times existed.
Because this computation added only two more participants into the analysis,
a subsequent ANOVA was employed. Instead o f post-test BDI-II scores, week-10
BDI-II scores were carried forward and placed into missing post-test and follow-up
cells respectively. This makes intuitive sense given only one week passed between
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session 10 and the post-test assessment time. This procedure added five more
participants into the analysis. Because therapists did not assess participants with the
RHRSD at session 10, this analysis was only completed using BDI-II scores.
In a final attempt to include all 17 participants in the collapsed group analysis,
a less conservative ANOVA was subsequently conducted. It was possible to include
all 17 participants by taking the mean BDI-II and RHRSD scores for the whole
distribution at a point in time (pre-, post-, and follow-up) and substituting that number
for the missing data for each variable accordingly. Finally, an intent to treat analysis
was performed on the entire sample to control for attrition.
Preliminary Analyses
Demographic information for the entire sample (i.e., completers and dropouts)
is displayed in Table I. O f the 17 participants who completed the study, 65% were
male (n = 11) and 35% were female (n = 6). The mean age o f participants was 37.8
years old with a range from 20 to 61 years o f age. At the time o f evaluation, the
racial composition o f the group was 94% Caucasian and 6% Alaskan-American.
Nearly one-half o f the participants were divorced (47%); the remainder was
single/never m arried (41%), or married (12%). All participants in the study reported
receiving their high school diploma. A total o f 12% o f the group completed high
school or received their GED, 47% reported their years o f education as more than 12
years, but less than 16, while 18% received at least 16 years o f schooling, and 23%
reported receiving 16-plus years o f education. The household income o f the group
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Table I
Demographic Variables for Completers, Dropouts and the Total Sample

Variable

Gender
Male
Female

11
6

Mean Age
Ethnic Group
African American
Hispanic
International
Alaskan American
Caucasian
Did Not Report

Dropouts
(n = 14)

Completers
(n = 14)
(64.7%)
(35.3%)

8
6

37.8

(57.1%)
(42.9%)

Total Sample
(n = 13)

19
12

38

(61.3%)
(38.7%)
37.9

0
0
0
I
16
0

( 0.0%)
( 0.0%)
( 0.0%)
( 5.9%)
(94.1%)
( 0.0%)

I
I
I
0
10
I

( 7.1%)
( 7.1%)
( 7.1%)
( 0.0%)
(71.4%)
( 7.1%)

1
I
1
1
26
1

( 3.2%)
( 3.2%)
( 3.2%)
( 3.2%)
(83.9%)
( 3.2%)

Relationship Status
Single, Never Married
Divorced
Married

7
8
2

(41.2%)
(47.1%)
(11.8%)

5
3
6

(35.7%)
(21.4%)
(42.9%)

12
11
8

(38.7%)
(35.5%)
(25.8%)

Years o f Education
Less than 12 Years
12 Years or GED
More than 12, Less than 16
16 Years
16+ Years

0
2
8
3
4

( 0.0%)
(11.8%)
(47.1%)
(17.6%)
(23.5%)

2
3
5
0
4

(14.3%)
(21.4%)
(35.7%)
(0.00%)
(28.6%)

2
5
13
3
8

( 6.5%)
(16.1%)
(41.9%)
( 9.7%)
(25.8%)

Household Income
Under $10,000 Per Year
$10,000 to $20,000 Per Year
$20,000 to $30,000 Per Year
Over $30,000 Per Year
Did Not Report

4
5
4
4
0

(23.5%)
(29.4%)
(23.5%)
(23.5%)
(0.00%)

4
2
3
3
2

(28.6%)
(14.3%)
(21.4%)
(21.4%)
(14.3%)

8
7
7
7
2

(25.8%)
(22.6%)
(22.6%)
(22.6%)
( 6.5%)
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was 24% earning under $10,000/year, 29% between $10-20,000/year, 24% between
$20-30,000/year, and 23% earned over $30,000/year.
Background data related to mental health history was also collected for each
person who completed and dropped out o f the investigation (see Table 2). O f the 17
completers, 13 participants entered the study with an Axis I diagnosis o f Major
Depressive Disorder, Recurrent/Moderate, while two participants were diagnosed
with Major Depressive Disorder, Recurrent/Severe without psychotic features. One
participant suffered from Major Depressive Disorder, Recurrent/Mild and one from
Major Depressive Disorder, Single Episode/Mild. It should also be noted that the
SCID-NP also identified three participants with Dysthymia, rendering them a formal
diagnosis o f “double depression.” No participants obtained a formal Axis II
diagnosis. On Axis

in, one participant reported high blood pressure, one suffered

from high cholesterol, one reported carrying a diagnosis o f multiple sclerosis, and one
reported having diabetes. Twelve participants did not qualify for an Axis III
diagnosis. For Axis IV, one participant reported parent/child relational problems, one
reported economic problems, two participants reported relational problems-NOS, and
six participants reported occupational problems. Furthermore, seven participants
reported a secondary Axis IV diagnosis o f problems with primary support group (n =
3), relational problems-NOS (n = 1), parent/child relational problems (n = I),
academic problems (n = I), and economic problems (n = 1). One participant was
given a third Axis IV diagnosis o f occupational problems. Five participants were not

53

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

Table 2
Clinical Characteristics o f Completers and Dropouts

Completers
(n = 17)

Variable

Dropouts
(n = 14)

Medication Status
Yes
No

5
12

(29.4%)
(70.6%)

6
8

(42.9%)
(57.1%)

Current RX
Prozac
Celexa
Paxil
Remeron
Did Not Report

2
2
I
0
0

(11.8%)
(11.8%)
( 5.9%)
(0.00%)
(0.00%)

2
0
I
I
2

(14.3%)
(0.00%)
( 7.1%)
( 7.1%)
(14.3%)

11
6
0

(64.7%)
(35.3%)
(0.00%)

13
0
1

(92.9%)
(0.00%)
( 7.1%)

6
2
0
1
2
0

(35.3%)
(11.8%)
(0.00%)
( 5.9%)
(11.8%)
(0.00%)

0
3
2
0
4
5

(0.00%)
(21.4%)
(14.3%)
(0.00%)
(28.4%)
(35.7%)

Previous TX for MDD
Yes
No
Did N ot Report
Number o f TX Episodes
0
I
2
3
4 o r more
Did N ot Report

Note. RX = Prescription; TX = Treatment; MDD = M ajor Depressive Disorder.
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given an Axis IV diagnosis. Finally, the Axis V Global Assessment o f Functioning
(GAF) scores ranged from 51-68, with a mean GAF o f 60.
When asked to describe any existing treatment for depression at the time o f
the initial screening, five participants (29.4%) reported taking one psychotropic
medication to treat their depression. Two o f those participants reported taking
Prozac, two were being treated with Celexa, and one reported taking Paxil. A
m ajority o f participants (70.6%; n = 12) reportedly were not using medication for
their depression. All 17 participants reported they were not concurrently receiving
another type o f psychotherapy. In regards to previous episodes o f treatment for
depression, two participants reported they had received one previous episode o f
treatment, one had received three previous episodes o f treatment, and two participants
reported receiving four o r more episodes o f treatment for their depression in the past.
Twelve participants reported this episode o f treatment as their first.
Demographic information for dropouts (i.e., those who terminated treatment
before completing at least six sessions) is also displayed in Table I. O f the 14
dropouts, 8 (57.1%) were male and 6 (42.9%) were female. The mean age for this
sample was 38 years old, with a range from 19 to 66 years o f age. The racial
composition o f this group was 71.4% Caucasian, while African-American, Hispanic,
and intemational/non-US citizen each made up 7.1%. One person did not report their
ethnicity. Forty-three percent o f dropouts were married; the remainder was
single/never married (35.7%) or divorced (21.5%). Two individuals (143% ) who
dropped out o f the study reported not completing high school, 21.4% reported
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completing high school o r GED, while the remaining 64.3% reported their years o f
education as more than 12 years o f education. The household income o f this group
was 28.6% earning under $ 10,000/year, 14.3% between $10-20,000/year, 21.4%
between $20—30,000/year, and 21.4% over $30,000/year.
The clinical characteristics o f those who dropped out are also shown in Table
2. All 14 dropouts entered the study with an Axis I diagnosis o f M ajor Depressive
Disorder. Over half (57.1%) o f the dropouts reported their depression as
recurrent/moderate. Moreover, single and recurrent episode/moderate and recurrent
episode/severe each made up 14.3%. On the remaining axes, those who terminated
treatment prematurely did not report clinical information that made them significantly
different from those who completed treatment.
When asked to describe any existing treatment for depression at the time o f
the initial screening, slightly one-half o f dropouts (42.9%; n = 6) reported taking one
psychotropic medication. The remaining 57.1 % (n = 8) reportedly were not taking
medication for their depression. All 14 dropouts reported they were not concurrently
receiving another type o f psychotherapy, hi regards to previous episodes o f treatment
for depression, three participants reported they had received one previous episode o f
treatment, two had received two episodes o f treatment, and three reported receiving
four or more episodes o f treatment for their depression in the past. Five dropouts
reported this episode o f treatment as their first.
In regards to the point at which these individuals dropped out o f the
investigation, over one-half (64.3%; n = 9) o f the 14 dropouts terminated participation
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after intake but before they were randomized into the immediate treatment or waitlist
condition. O f the five people who actually began treatment, three were randomized
into the immediate treatment group and two into the waitlist group. Moreover, a
single person dropped out after session one, after session three and after session four,
while two people terminated after session two. Finally, it may be important to note
that those who dropped out were not significantly more or less depressed at the initial
screening than those who completed the study, according to the BDI-II, t(29) = 0.74,
p —ns, and the RHRSD, f(29) = 0.61,/? = ns.

Primary Analyses
The means, standard deviations, and results o f the between group analyses are
presented in Table 3 and Figure 2. The first point o f analysis consisted o f an

Table 3
Mean Pre-waitlist and Post-waitlist BDI-II Scores for W aitlist Participants
and Mean BDI-II Pretreatment, Post-treatment, and 3-Month Follow-up
BDI-H Scores for Treatment Participants

n

TX Group
M
SD

n

WL Group
M
SD

r(dfs) and p

Pre-

9

32.78

(6.3)

8

29.75

( 5.58)

r(15)=1.04,/? = ns

Post-

6

3.83

(3.3)

8

28.30

(16.32)

r(12)=3.58, p Z 0.004

Follow-up

6

7.17

(8-2)

8

28.30

(1632)

t(12)=2.88,/?Z0.02

Note. BDI-II = Beck Depression Inventory-Second Edition; T X = Treatment; WL =
W aitlist.
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Figure 2. Mean Pre-W aitlist and Post-W aitlist BDI-II Scores for W aitlist Participants
and Mean PreTreatment, Post-Treatment, and 3-Month Follow-up BDI-II
Scores for Treatment Participants.

independent-samples r-test to assess group differences at intake. There were no
significant differences at time o f initial intake on both the BDI-H, r(l 5) = 1.04, p = ns,
or the RHRSD, r(15) = 0.94, p = ns. This suggests that both immediate treatment and
waitlist conditions started treatment at comparable levels o f symptom severity (see
Table 4 and Figure 3).
The next point o f analysis examined group BDI-H means immediately
following treatment for those in the immediate treatment group and immediately
following the waiting period for those in the waitlist group. The results o f this
independent samples f-test was significant, r(12) = 3.58, p < 0.004, r = 0.72. In a
sim ilar analysis, an independent samples r-test compared group means at the same
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Table 4
BDI-II and RHRSD Scores at Pretreatment
TX Group fn = 91
M
SD

Variable

WL Group (n —22)
M
SD

*df) and p

BDI-H

32.8

(63)

29.8

(5.6)

r(15) = 1.04, p = 0.32

RHRSD

18.1

(4.0)

20.0

(4.2)

*15) = 0.94,p = 0.36

Note. TX = Treatment; WL = W aitlist; BDI-II = Beck Depression Inventory- Second
Edition; RHRSD = Revised Hamilton Rating Scale for Depression.
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Figure 3. Mean BDI-II and RHRSD Scores at Pretreatment.
point for the waitlist condition but at 3-month follow-up for the immediate treatment
condition. This analysis revealed statistically significant differences in mean BDI-II
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scores with /(12) = 2.88, p < 0.02, r = 0.64. These results suggest that treatment with
BA was superior to remaining on a waitlist and that it was simply not the passage o f
time that caused reductions in depression.
The next independent sample r-tests compared means at post-test on each
dependent variable and significant differences were found between the groups, with
f(6) = 2.63, p < 0.04, r = 0.73 on the BDI-II and t(5) = 5.04, p < 0.004, r = 0.92 on the
RHRSD. This result suggests that on both dependent measures, those in the
immediate treatment condition were significantly less depressed than those in the
waitlist condition after receiving BA treatment, but at the 3-month follow up,
significant differences were not found on the BDI-II [f(7) = 0.21,/? = ns], but
apparent on RHRSD scores, t(7) = 2.55, p < 0.04, r = 0.69. With respect to the
RHRSD, the significant difference suggested that the immediate treatment group
showed the greatest reduction in symptoms.
Although both immediate and waitlist groups started out with comparatively
sim ilar depression levels, after receiving treatment, one group appeared more
depressed than the other. This result should be interpreted cautiously as only two
waitlist condition participants entered into the analysis at post-test for each outcome
measure, and three waitlist condition participants at follow-up on each outcome
measure. Despite low participant numbers, effect sizes for each independent r-test
appear large enough to conclude that BA treatment is more effective in decreasing
depression when compared to a 6-week wait period and that participant’s depression
levels did not decrease simply due to passage o f time.
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The next set o f analyses was computed within-groups for the immediate and
waitlist conditions separately over three assessment times (i.e., pretest, post-test, and
follow-up) on both dependent measures (see Figures 4 and 5). For the immediate
treatment group, there was a significant reduction in BDI-II scores from pretest
through to follow-up, w ith F (2 , 8) = 82.15, p <0.001, eta = 0.97. Results were
sim ilar for RHRSD scores, with F ( 2, 8) = 140.77, p < 0.001. eta = 0.99. Given the
significant omnibus F-tests, within-subjects contrasts were computed on both
dependent measures. Significant reductions in scores were found between pretest and
post-test on the BDI-H, F (1,4) = 93.52, p < 0.001, eta = 0.98, and the RHRSD, F ( l ,
4) = 196.00, p < 0.001, eta = 0.99. Likewise, significant reductions in depression
scores between pretest and follow-up were found on the BDI-II, F ( l , 4) = 90.99,/? <
0.001, eta = 0.98, and the RHRSD, F ( l , 4) = 130.0,/? < 0.001, eta = 0.98. A final
within-subjects contrast examined means at post-test versus 3-month follow-up.
There was no significant differences found at these points on both the BDI-II, F ( l , 4)
= 0.022,/? = ns, and the RHRSD, F ( l , 4) = 3.33,/? = ns. These results suggest that
for those in the immediate treatment group, depression levels decreased significantly
overtim e. Furthermore, these individuals maintained treatment gains for at least
three months after finishing BA treatment.
Because only three participants finished treatment through to the 3-month
follow-up in the waitlist condition, it was not possible to conduct a repeated-measures
ANOVA on this group separately. Alternatively, paired samples f-tests were
performed on both dependent measures. The results o f the pretest to post-test
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Figure 4. Pretreatment, Post-treatment, and 3-Month Follow-up Means for BDI-H
Scores, by Condition.
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Figure 5. Pretreatment, Post-treatment, and 3-Month Follow-up Means for RHRSD
Scores, by Condition.
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comparison showed a significant reduction in BDI-H scores, with f(l) = 31.0, p =
0.02, but not RHRSD scores, with f(l) = 3.33, p = ns. The second comparison o f
means, between pretest and follow-up, showed no significant change in BDI-II
scores, with t{2) = 2.65, p = ns. On the contrary, a significant difference was found at
this same point in RHRSD scores, with t(2) = 4.5, p < 0.05. The comparison between
post-test and follow-up means could not be calculated, as there were not enough
participants to enter into the analysis.
In order to control for the relatively small sample size, the immediate and
waitlist groups were then combined, allowing for a within-subjects comparison from
intake to post-test to the 3-month follow-up. Prior to collapsing the two groups, it
was necessary to show that participants in the waitlist condition did not change (i.e.,
become significantly more or less depressed) from the initial screening to the end o f
the 6-week wait period. A repeated-measures ANOVA, examining the means at
pretest through to the end o f the 6-week waitlist period showed that participants’
depression levels remained uniformly the same, F (3,21) = 0.101, p = ns.
Given this non-significant finding, the immediate and waitlist conditions were
then collapsed and assessed for change over time. This analysis was performed for
all participants who completed at least six sessions o f treatment, regardless o f their
treatment condition. Although only 6 o f 17 participants completed all outcome
measures at pretest, post-test and follow-up, results revealed a significant reduction in
both BDI-II scores, F ( 2 ,10) = 47.34,/? <0.001, eta = 0.95, and RHRSD scores, F (2,
10) = 83.68, p <0.001, eta = 0.97. Furthermore, within-subject contrasts revealed a
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significant reduction in BDI-H scores from pretest to post-test, F (1,5) = 70.68, p <
0.001, eta = 0.97, and in RHRSD scores at that same assessment point, F (1, 5) =
81.22,/? < 0.001, eta = 0.97. Similarly, within-subjects contrasts revealed a
statistically significant reduction in BDI-II scores from pretest to follow-up, F ( l , 5) =
40.86, p = 0.001, eta = 0.99, and in RHRSD scores at that same assessment point, F
(1, 5) = 116.02, p < 0.001, eta = 0.98. Depression levels remained at a relative
constant from post-test to follow-up as significant differences were not found on both
the BDI-II, F ( l , 5) = 0.30, p = ns, or the RHRSD, F (1, 5) = 0.56, p = ns.
In the next analysis, post-test scores for each participant were carried forward
to complete the missing follow-up data where necessary. A repeated-measures
ANOVA on the total sample revealed a significant reduction from pretest through to
the 3-month follow-up on both the BDI-H, F ( 2, 14) = 66.69, p < 0.001, eta = 0.95,
and the RHRSD, F (2,12) = 117.59, p < 0.001, eta = 0.98. Further within-subject
contrasts unveiled a significant reduction in BDI-II scores from pretest to post-test, F
(1, 7) = 89.33,/? < 0.001, eta = 0.96, and in RHRSD scores from pretest to post-test, F
(1,6) = 114.09, p < 0.001, eta = 0.97. Similarly, within-subjects contrasts revealed a
statistically significant reduction in BDI-II scores from pretest to follow-up, F ( l , 7) =
59.7, p < 0.001, eta = 0.95, and in RHRSD scores at the same assessment point, F (1,
6) = 163.36, p < 0.001, eta = 0.98. Depression levels remained a t a relative constant
from post-test to follow-up as significant differences were not found on both the BDIII, F ( l , 7) = 0.31, p = ns, o r the RHRSD, F ( l , 6) = 0.56, p = ns.
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Unfortunately this computation added only two m ore participants (n = 8) into
the analysis, so a sim ilar ANOVA was employed increasing the sample size to 13.
For those who finished ten weeks o f BA, their 10-week BDI-H score was carried
forward and placed into missing post-test and follow-up cells respectively. The
results yielded a statistically significant difference over time from pretest through to
follow-up, F (2 , 24) = 73.00, p < 0.001, eta = 0.93. Further within-subjects contrasts
revealed exactly where those differences existed. As would be expected, there was
significant differences between pretest and post-test, F ( l , 12) = 87.81, p < 0.001, eta
= 0.94, and between pretest and follow up, F (1, 12) = 83.64, p < 0.001, eta = 0.94.
Participants BDl-H scores stayed relatively constant from post-test to follow-up, F ( l ,
12) = 0.96, p = ns.
So as to include all 17 participants and increase the power in the collapsed
group analysis, a less conservative ANOVA was subsequently conducted (see Table S
for means and standard deviations and Figure 6). It was possible to include all 17
participants by taking the mean BDI-II and RHRSD scores for the whole sample at a
given point in time, and placing that mean into the missing data for each variable
accordingly. Statistically significant differences were found from pretest through to
follow-up on the BDI-H, F (2,32) = 180.69, p < 0.001, eta = 0.96, and on the
RHRSD, F ( 2 ,32) = 223.19, p < 0.001, eta = 0.97. Given the significant results,
further within-subject contrasts were computed. Significant differences were found
between pretest and post-test on the BDI-II, F (1,16) = 266.89, p < 0.001, eta = 0.97,
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Table 5
Pretreatment, Post-treatment, and 3-Month Follow-up Means
for BDI-n and RHRSD Scores for the Total Sample
Depression Measure

n

BDI-H
Across time
PrePostFollow-up

17
17
17
17

RHRSD
Across time
PrePostFollow-up

17
17
17
17

M

3135
5.94
7.76

19.0
3.82
4.0

(SD)

F(dfs) and p

(6.0)
(3.4)
(5.2)

F ( 2, 32) = 180.69, p < 0.00l a
F ( l , 16) = 266.89, /?< 0.001b
F ( l , 16) = 1.92,/? < nsc
F (1,16) = 220.58, p < 0.0 0 ld

(4.1)
(1-8)
(1.3)

F (2,32) = 223.19, p < 0.001“
F ( l , 16) = 228.25,/? < 0.001b
F ( l , 16) = 0.21,/? <0.00 l c
F ( l , 16) = 255.00,/? < 0.001d

Note. BDI-H = Beck Depression Inventory-Second Edition; RHRSD = Revised
Hamilton Rating Scale for Depression; TX = Treatment; WL = W aitlist,
“pretreatment to post-treatment to follow-up;
bpretreatment to post-treatment;
c post-treatment to follow-up;
dpretreatment to follow-up.
and on the RHRSD, F ( l , 16) = 228.25,p < 0.001, eta = 0.97. Similar differences
were found between pretest and 3-month follow-up on both outcome measures, F ( 1,
16) = 220.58, p < 0.001, eta = 0.97, on the BDI-H, a n d F (l, 16) = 255.0,/? < 0.001,
eta = 0.97, on the RHRSD. Statistically significant differences were not found
between post-test and 3-month follow-up on BDI-H scores, F (1,16) = 0.96, p = ns,
and RHRSD scores, F ( l , 16) = 0.21,/? = ns.
Although calculated in different manners, these various analyses for the total
sample suggest that a significant reduction in depression scores existed from
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Figure 6. Pretreatment, Post-treatment, and 3-Month Follow-up Means for BDI-H
and RHRSD Scores for the Total Sample.
pretreatment to post-treatment, while those gains were maintained respectively at the
3-month follow-up point. Overall, it implies that depression levels decreased
significantly for those participants who received six or more sessions o f BA.
Intent-to-Treat Analyses
In order to control for participants who dropped out o f the study, an intent-totreat analysis was performed by utilizing the dropouts’ pretest scores on both
dependent measures as their post-treatment scores. The following analysis is
particularly meaningful for this study due to the high attrition rate, established at
approximately 45% (14 o f 31 participants dropped out).
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Because this analysis assumes that those who prematurely dropped out o f the
study achieved no gains from BA treatment, this is considered a conservative
analysis. This analysis guides our understanding regarding whether BA was effective
for the entire sample, as opposed to just those who completed the study. For the
intent-to-treat analyses, changes in BDI-H scores, RHRSD scores, and changes in
diagnosis from pretest to post-test were examined. Paired samples r-tests showed a
significant reduction in depression symptomatoloy in both BDI-II scores, r(31) =
6.24, p < 0.001, r = 0.75, and RHRSD scores, r(31) = 2.86, p < 0.01, r = 0.46. These
analyses suggest that even when controlling for dropouts, BA was associated with a
significant reduction in depression levels. Furthermore, BA was associated with a
significant reduction in the number o f Major Depression diagnoses from pretest to
post-test, even when dropouts were factored into the analysis, f(30) = 3.23, p < 0.01, r
= 0.51.

Post-hoc Analyses
In order to clarify the role o f behavioral activation in the treatment o f more
“real world” people who suffer from Major Depressive Disorder, comparisons were
made between persons who were and were not being treated w ith psychotropic drugs.
These are the people who realistically present themselves in practice settings for
treatment. Therefore, a set o f post-hoc analyses were conducted by separating those
participants who were receiving independently prescribed pharmacological treatment
for depression while receiving B A from those who were receiving only BA (i.e.,
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medication participants versus no medication participants). Each sample was
examined at three assessment points (i.e., pretest, post-test, and follow-up) and mean
BDI-II and RHRSD scores served as dependent variables. For this sample o f
participants who completed the treatment, approximately one-third (29.4%) were
taking medications for their depression (n = 5).
Due to similar attrition problems as seen in previous analyses, a more liberal
analysis was computed to increase the number o f participants entered into the
analysis. For all between-group and within-group computations, the mean post-test
and follow-up score for that sample was substituted for missing data at each
respective assessment point. Independent samples r-tests with medication status as
the independent variable and BDI-II and RHRSD scores as dependent variables
revealed non-significant findings at each assessment point (see Table 6 and Figures 7
and 8 for details). More specifically, statistically significant differences were not
found at pretest on both the BDI-H, /(15) = 1.09, p = ns, and RHRSD, r(l5) = 1.33,/)
= ns. Also at post-test, results revealed no significant difference between the two
groups on the BDI-H, r(I5) = 1.58, p = ns, and RHRSD, f(15) = 0.91, p = ns. The
same followed at the 3-month follow up, with no significant differences found in
BDI-H scores, r(l5) = 0.62,p = ns, and RHRSD scores, f(15) = 1.28,p = ns. This
analysis suggests that those taking medication did not have higher or lower BDI-H or
RHRSD scores (M =33.8) prior to starting treatment than those who were not taking
medication (M = 30.3). Furthermore, after receiving BA treatment, those that were
taking medication did not achieve significantly lower or higher BDI-H or RHRSD
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Table 6
Pretreatment, Post-treatment, and 3-Month Follow-up Means
for BDI-H and RHRSD Scores as a Function o f Medication Status
Medication

No Medication
n
M
SD

n

M

SD

f(dfs)and p

BDI-H
Pre-

12

30.33

(5-2)

5

33.8

(8.7)

r(l5) = 1.09, p=ns

Post-

12

6.75

(3.5)

5

4.0

(2.3)

f(6) = 1.45, p=ns

Follow-up

12

7.25

(3.5)

5

9.0

(8.5)

r(7) = 0.59,/?=ns

RHRSD
Pre-

12

19.83

(4.0)

5

17.0

(4.1)

r(15) = 1.33, p=ns

Post-

12

4.08

(2.0)

5

3.2

(1.3)

t(5) = 0.88, p=ns

Foilow-up

12

4.25

(1.4)

5

3.4

(0.9)

t{7) = 1.21, p=ns

Note. BDI-H = Beck Depression Inventory-Second Edition; RHRSD = Revised
Hamilton Rating Scale for Depression.
scores than those who received BA singly. Thus, this analysis does not argue for an
additive effect o f medication in this investigation.
A more conservative between-group comparison in which exact pretest, post
test and follow-up data were examined between the medication versus no
medication participants showed very similar results as above, with no significant
differences found at any assessment point on both outcome measures. Again at
pretest, participants did not differ significantly on their BDI-H or RHRSD scores,
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r(l 5) = 1.09, p = ns, and /(15) = 1.33,/? = ns. Similar results followed at post-test on
BDI-H and RHRSD scores, f(6) = 1.47, p = ns; /(5) = 0.88, p = ns, and at the 3-month
follow-up on BDI-H and RHRSD scores, f(7) = 0.59,/? = ns; t(7) = 1.21,/? = ns.
In order to describe how each group o f participants responded to BA
separately, within-group computations were executed. For those being treated with
both medication and BA, a repeated-measures ANOVA was executed, again
implementing the more liberal procedure in which whole sample post-test and followup means are substituted for missing post-test and follow-up data respectively. This
analysis was chosen over the more conservative procedure o f using exact pre-, po st
and follow-up means as only two participants entered into that particular analysis.
Results displayed a significant decrease over time from pretest to post-test through to
follow-up on both BDI-n scores, F (2, 8) = 54.03, p < 0.001, eta = 0.96, and RHRSD
scores, F ( 2, 8) = 59.22, p < 0.001, e ta =0.97. Further within-subjects comparisons
were made to detect where exact reductions in depression scores appeared.
Statistically significant differences were found from pretest to post-test on the BDI-H
and RHRSD, F ( l , 4) = 102.78,/? = 0.001, eta = 0 .9 8 ;F (1 ,4) =67.06, p = 0.001, eta
= 0.97, and from pretest to the 3-month foUow-up on the BDI-H and RHRSD, F ( l , 4)
= 65.85, p = 0.001, eta = 0.97; F ( l , 4) = 56.74, p = 0.002, eta = 0.97. Depression
levels remained relatively constant for this group from post-test to follow-up as no
significant differences were revealed between these assessment points on either the
BDI-H, F ( l , 4) =2.43,/? = ns, or the RHRSD, F ( l , 4) =0.17,/? = ns.
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Similar reductions in BDI-H and RHRSD scores overtime were found for
those participants receiving BA singly. As in the previous analysis, the more liberal
ANOVA procedure was instituted, as opposed to comparing exact means due to low
sample sizes included in this analysis. Results displayed a significant decrease over
time from pretest to post-test through to follow-up on both BDI-II scores, F ( 2 , 22) =
139.48,/? <0.001, eta = 0.96, and RHRSD scores, F ( 2 ,22) = 161.67, p <0.001, eta =
0.97. Given this finding, within-subjects comparisons were made. Statistically
significant differences were found from pretest to post-test on the BDI-II and
R H R S D ,F (l, 11) = 210.41,/? <0.001, eta = 0.98; F ( l , 11) = 160.32,/? <0.001, eta
= 0.97, and from pretest to follow-up on the BDI-II and RHRSD, F ( l , 11) = 143.86,
p <0.001, eta = 0 .9 6 ;F (l, 11) = 199.20,/? <0.001, eta = 0.97. Depression levels
remained relatively constant for this group from post-test to the 3-month follow-up as
no significant differences were found between these assessment points on either the
B D I -n ,F (l, 11) =0.17,/? = ns, or RHRSD, F ( l , 11) = 0.10,/? = ns. Overall, the

post-hoc analyses suggest that in this investigation the addition o f medication to BA
treatment does not significantly reduce depression levels any more than treatment
with BA alone.

Diagnostic Outcome and Recovery
In order to assess for clinically significant decreases in depressive
symptomotology, this investigation also compared the number o f participants who
met DSM-rV criteria at initial screening to those who met criteria after receiving
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treatment with BA. The Structured Clinical Interview for DSM-IV determined
diagnostic outcome.
At the initial screening, all 17 completers (100%) met DSM-IV criteria for
Major Depressive Disorder. At the end o f treatment, o f the three that returned for
assessment at post-test, no participants met DSM-IV criteria for Major Depressive
Disorder. Similarly, at the 3-month follow-up point, no participants out o f the four
that returned for assessment met DSM-IV criteria for Major Depressive Disorder.
This information obtained from the SCID suggests that all participants who returned
for post-test and/or follow-up assessments showed reductions in depressive symptoms
o f a large enough magnitude such that they no longer rendered a formal DSM-IV
diagnosis o f Major Depressive Disorder.
In an attempt to further assess clinical significance, recovery rates for Major
Depression were also investigated. Similar to cutoffs used in the Jacobson et al.
(1996) study, those participants who can be considered “recovered” have scores o f
less than eight on the BDI-H at post-treatment. Because o f the low sample size at
post-test for this study, the last data point for each participant was investigated. For
this sample, approximately one-third (35%) o f completers can be classified by the
BDI-H as “recovered” from Major Depressive Disorder attributable to BA, as
compared to the 50-60% o f participants considered “recovered” in the Jacobson et al.
(1996) study. It may be important to note that only three o f 17 participants (18%)
could still be considered clinically depressed at post-treatment, according to a score
o f 20 o r higher on the BDI-H.
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Treatment Adherence

In order to be certain that the treatment delivered from the prescribed manual
was in fact BA, treatment integrity data were collected on each participant who
completed the study. Trained observers were provided with a modified version o f the
National Institute o f Mental Health Collaborative Study Psychotherapy Rating Scale
(CSPRS; Hollon et al., 1984) that included the steps in BA, along with a checklist o f
prescribed BA techniques and proscribed cognitive therapy techniques.
A random sample o f the video taped treatment sessions (11%) was reviewed
separately by two different observers (representing 53% o f participants on whom
treatment integrity was completed). Both observers checked o ff the presence o f each
step in the outline, along with the specific treatment interventions used that session.
All therapists were included in the reviewed sample.
In order to determine where rater discrepancies appeared, checklist
compliance percentages for the most relevant items was first computed. On 100% o f
the observed occasions, raters responded “yes” to the checklist item, “therapist
implemented behavioral activation interventions.” Furthermore, on 100% o f the
observed occasions, raters responded “no” to the item, “therapist did use cognitive
interventions,” indicating cognitive therapy was not implemented at any point
throughout treatment in the observed sessions. This is key to treatment integrity as it
strongly suggests that therapists in fact administered BA, and not cognitive therapy,
to the participants.
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Also important in the delivery o f BA was the adherence to the prescribed
treatment protocol in terms o f completing all procedural components. On 94% o f
observed occasions, therapists asked participants to complete the BDI-II at the
beginning o f the session and then reviewed the questionnaire, examining overall
scores and key items as that which endorsed suicidal ideation and participation in
activity. Furthermore, therapists and participants reviewed the previous weeks’
homework on approximately 94% o f the observed sessions and then presented
homework to be completed over the upcoming week.
Finally, inter-rater reliability was performed on the final judgment, which
examined the number o f agreements divided by the number o f agreements plus
disagreements. The inter-rater reliability correlation was .88, showing that the raters
agreed 88% o f the time that therapists were delivering BA according to the protocol
described in the treatment manual.
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CHAPTER V

DISCUSSION
The purpose o f the present study was to test the effectiveness o f behavioral
activation with medicated and unmedicated clients who realistically presented for
treatment in a more “real-world” setting. The aim o f this study was to conduct a
quasi-replication o f the basic findings noted in the Jacobson et al. (1996) study, which
concluded that the BA component o f CBT was as successful as the full treatment
package in reducing depression and altering negative thinking and attributional styles.
It was hypothesized that at the completion o f therapy, participants in both the
treatment and waitlist conditions would be significantly less depressed on both a selfreport measure and a clinician rating o f symptom severity.

Main Outcomes
The results o f this study support BA as an efficacious therapeutic tool to treat
major depression and suggest that activation strategies alone may be sufficient to
produce behavioral and cognitive changes that significantly reduce depressive
symptoms. Conclusions are based on between-group differences, which showed that
though both treatment and waitlist conditions started out at comparable levels o f
symptom severity, the treatment group had a better response to BA than those in the
waitlist group at post-treatment. These differences were maintained at the 3-month
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follow-up according to the RHRSD. Essentially, both treatment and waitlist
condition participants experienced a significant decrease in depressive symptoms, but
with respect to a clinician-rated assessment, the treatment group showed a greater
reduction in symptoms. These results should be interpreted with caution due to the
low sample size in the waitlist group.
Further statistical comparisons between groups support the efficacy o f BA.
For instance, the comparison made between the end o f the wait period for the waitlist
group and post-treatment for the treatment group showed that end o f treatment means
were significantly lower than end o f the wait period means. These results are
especially meaningful in that they suggest that treatment with BA is superior to
remaining on a waitlist and that it was not simply the passage o f time or spontaneous
remission that accounted for apparent decreased symptomatology in this sample.
The inclusion o f the waitlist control group and their absence o f change over a
6-week wait period in depression symptoms bolster this conclusion. Essentially,
participants in the waitlist group showed no significant reduction in BDI-II scores
over the course o f the wait period, again suggesting that the passage o f time was not
sufficient to decrease depressive symptomatology. Moreover, as waitlist participants
began treatment with BA, they subsequently experienced a reduction in
symptomatology.
In sum, those in the treatment group showed a significant decrease in
depression, as they experienced a shift; from moderate/severe to mild depression (as
measured by the BDI-II). Those who were in the waitlist control group, waiting for
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treatment to begin, did not show improvement over the 6-week wait period. Put
simply, for this sample, when treated with BA, people experienced a decline in
depression symptoms. Without treatment, depression levels falling in the
moderate/severe range remained relatively the same.
Given that the treatment and waitlist conditions experienced a significant
reduction in depression when assessed separately, it makes intuitive sense that after
combining the groups, BA still fared well. Overall, depression levels significantly
decreased for those who received six or more sessions o f BA. Furthermore, there
were no significant differences between the end o f treatment and 3-month follow-up
scores on both outcome measures. More specifically, for this sample, even three
months after treatment ended, significant reductions in depression were still evident.
As noted by Gortner et al. (1998), this comparison is important as it allows for the
determination o f the “ultimate impact o f therapy,” showing both acute and longerterm responses to treatment (p. 379). This is an important point to highlight given the
greatest risk for relapse is during the immediate post-recovery period, typically
around the first few months after symptoms remit (Keller, Lavori, Lewis, & Klerman,
1983; Maj, Veltro, Pirozzi, Lobrace, & Magliano, 1992).
Moreover, this sample as a whole scored in the moderate/severe range o f
depression (M = 30.6) at the initial screening, according to the BDI-II. After
receiving at least six weeks o f treatment, the post-treatment mean (Af = 8) placed this
group in the minimal clinical depression category. This finding is similar to the BA
group in the Jacobson et al. (1996) study in which participants also moved from a
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moderate/severe level o f depression to mild clinical depression, as measured by the
BDI-H. Furthermore, 15 out o f 17 participants (88.3%) who entered this study
initially described themselves as suffering from chronic, recurrent depression. This is
not surprising given the risk for repeated episodes o f depression is approximately
80% and isolated depressive episodes are rare (14%; Judd, 1997). This closer
examination o f symptom severity and chronicity is meaningful in showing that BA
was not simply sustaining a group o f people suffering from a mild or subclinical level
depression, or primarily those experiencing their first single episode o f depression. It
had a considerable effect on a difficult to treat population, those primarily suffering
from moderate to severe cyclical depression, quite possibly for a number o f years.
Given these findings, one cannot dispute the clinical effectiveness o f BA for
the treatment o f major depression. Questions as to its theory o f change and the
decision to use BA singly o r in combination with CT, therefore need to be addressed.
Dating back to 1984, treatment outcome researchers began to question the cognitive
component o f CBT for depression, pondering whether “changing beliefs necessarily
solves the clinical problem” (Latimer and Sweet, 1984, p. 21). As Latimer and Sweet
(1984) critically reviewed the evidence for the efficacy o f procedures specific to
behavioral and cognitive therapy, they inquired whether the cognitive piece o f CBT
was a direct mechanism o f change, or i f the clinical shift was due to the use o f
behavioral procedures o f established efficacy. Based on their review o f 11 studies, it
was concluded that because CT usually involves a variety o f methods including
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behavioral procedures, it’s questionable whether the cognitive piece alone makes a
significant contribution to therapeutic outcomes.
Over the next decade, this line o f inquisition spawned much theoretical
debate, along with a line o f solid clinical research comparing combined cognitivebehavioral treatment packages. A further review o f treatment outcome research,
published from 1982 through to 1989 (Sweet & Loizeaux, 1991), examined 70
articles that addressed the essential question: “Does the specific addition o f a purely
cognitive therapeutic procedure enhance the outcome o f behavioral treatment
methods for actual patient populations?” In this comparative review, most studies
reflected an equivalence in outcome between CBT procedures and behavioral
procedures alone, therefore allowing the authors to conclude that the behavioral
aspect o f CBT was central to its effectiveness, while the same could not be said for
the cognitive component. Given this conclusion, the authors ingeniously proposed
the need for clinical researchers to dismantle CBT.
As noted by Beidel and Turner (1986), the relationship between behavior and
cognitive change is “complex and interactive, with change in one domain promoting
change in the other” (p. 188). These authors have suggested that we can get positive
outcome from behavior therapy alone, without the cognitive component, because
behavioral activities provide a mechanism through which distorted cognitions can be
evaluated, thus rendering a subsequent cognitive sh ift Furthermore, as patients are
encouraged in CBT to evaluate their thoughts in a more critical light, it has been
argued that what they are actually attending to is a more careful self-monitoring o f
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environmental contingencies, which fits nicely into a stimulus discrimination
paradigm. As patients are encouraged to try new behaviors and monitor the
consequences, cognitive change occurs as a result. This then describes CBT as not
very different from the more traditionally oriented behavior therapy, as both look to
change overt and covert maladaptive depressive behaviors (Biedel & Turner, 1986).
This investigations’ ability to show that in and o f itself, BA is an effective
treatment for depression, supports these theoretical underpinnings and refutes what
cognitive therapists have long said about the mechanisms o f action in CBT for
depression. First described in the Jacobson et al. (1996) study, it was suggested that
BA can be just as effective as the full CBT treatment package because as reinforcers
are returned to depressives’ lives, BA functions to change the way people think more
effectively than explicit cognitive interventions. This line o f reasoning supports
traditional behavioral theory, which stresses the importance o f learning histories for
subsequent variation in cognitive content, and helps explain why BA may stand alone
as an efficacious treatment intervention for major depression.
Secondary Outcomes

In this investigation, comparisons were made post-hoc between persons who
were and were not being treated with psychotropic drugs. This was done so as to
clarify the role o f BA in the treatment o f more “real world” people who suffer from
m ajor depression. As noted by Burrows (1992), when patients present for therapeutic
treatment for depression in a clinic setting, many are already taking psychotropic
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medication, leaving psychotherapists to contend with existing medication regimes.
Therefore, this study set out to simulate a typical clinical setting as much as possible,
thus making this important post-hoc comparison.
The medication and no medication groups were statistically compared at
pretreatment, post-treament, and the 3-month follow-up. While within-group
comparisons revealed both groups experienced significant reductions in depressive
symptoms, neither group proved superior to the other with regard to both outcome
measures. Essentially, the combination o f preexisting medication and BA did not
provide a clinically meaningful advantage over BA alone.
While preexisting medication did not seem to hinder the recovery o f those in
the medication and BA treatment group, it appears that medication also did not
enhance positive treatment outcome. One might argue that because combining the
two interventions did not exceed that o f BA alone, it would be more cost-effective to
use BA singly. As suggested by Antonuccio, Thomas, and Danton (1997), in an era
o f managed care, treatment must not only be effective, but also cost-effective. In a
study conducted by these same authors in which acute and long-term outcomes and
dropout/relapse rates were considered over a 2-year period, medication alone resulted
in 33% higher expected costs than individual CBT treatment, while the combination
o f treatments resulted in 23% higher costs than CBT alone. Although only one study,
it makes a strong argument that getting treated with therapy alone can be greatly costeffective in comparison to treatment with medication alone or some combination o f
therapies. This cost-effective model bodes well for BA as a single therapeutic tool,
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which proved for this sample to be efficacious for treating depression whether
patients were taking antidepressant medication or not.
One might ask why two therapeutic interventions were not more effective in
this investigation for reducing depression symptoms than a single approach. Not only
has some preliminary evidence supported the fact that patients who improve with
cognitive-behavioral therapy show similar biological changes than those who
improve with psychotropic medication (Antonuccio, Danton, DeNelsky, Greenberg,
& Gordon, 1999), but it is also possible that those who were prescribed a medication
regime were not completely compliant. Non-adherence to antidepressant medication
regimes is not uncommon, as the research suggests that 40—50% o f patients
prescribed an antidepressant will not take it for the maximum period needed to
achieve therapeutic gains. Discontinuing the medication because o f undesirable side
effects is also common (Schulberg, Katon, Simon, & Rush, 1999). With this sample,
it is possible that the medication participants who were reportedly taking their
medication as prescribed had in fact discontinued it over the 10-week treatment
period or were not taking it consistently. Similarly, it is possible that participants
were not taking the therapeutic dosage (i.e., dosages were suboptimal) necessary to
clinically reduce depression. Because participants’ medication compliance and
dosage levels were not monitored by present investigators at any point during their
involvement in the study, it is impossible to know exactly how compliant they were
with their regimes.
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Treatment outcome literature in depression, investigating whether medication
has an additive effect to therapeutic treatment, has shown mixed results. While some
studies suggest the combination o f psychotropic medication and CBT are more
efficacious than either alone (Hollon et al., 1991; Hollon et al., 1992), a number o f
other studies have found similar results to that o f this investigation, arguing that
medication does not add anything to the existing therapeutic tool. For instance, in a
quasi-experimental study conducted by Oei and Yeoh (1999), it was hypothesized
that pre-existing medication would enhance treatment outcome for those receiving
group CBT for depression, as compared to those coming into the study not taking
medication. After 12 sessions o f group CBT over a 3-month period, the authors
actually found the opposite o f their proposed hypothesis. Results indicated that pre
existing medication did not enhance or detract from the positive treatment outcome
that participants experienced. Although a group format was investigated here, results
are in line with those o f this investigation, which also concluded that concurrent drug
intake did not produce an additive effect to the psychotherapy portion o f treatment.
In conclusion, the results regarding the additive effect o f medication and BA
should be interpreted cautiously as the possible lack o f uniformity in medication
regimes and dosages may have biased the results. On the contrary, one cannot
dismiss these findings as the goal o f this study was not that o f rigorous control, as in
“efficacy” research, but to simulate real-world clinical samples, while also adding to
the smaller body o f “effectiveness” research literature. Further research is needed in
this area to uphold these findings (Oei & Yeoh, 1999).
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Limitations o f This Study
There are a number o f limitations o f the current study that merit discussion.
The most notable is the small sample size, due to large attrition rates and difficulty
with recruitment. As noted by Persons, Bums, and Perloff (1988), it is expected that
in controlled research settings, participant dropout rates are lower than those seen in
private clinic settings for several reasons: participants agree to a fixed number o f
sessions at the start o f treatment, the cost o f treatment is typically substantially
reduced, research subjects are likely to be high in motivation given that they must
apply and go through rigorous screening procedures, and great efforts are made by
researchers to follow up missed sessions. Despite similar circumstances in this
investigation, the dropout rate remained relatively high (45%), although not unlike
dropout rates seen in psychiatric community outpatient clinics, which typically range
from 20-60% (Simons, Levine, Lustman, & Murphy, 1984), and other effectiveness
studies that describe a dropout rate between 40-60% (Chambliss & Ollendick, 2001).
Throughout the literature, many reasons for dropping out o f treatment
prematurely have been noted. For instance, if a patient shows resistance to change or
to the treatment process itself attrition rates are likely to increase (Davis & Addis,
1999). In this study the therapy itself required patients to learn, utilize and practice
active coping skills on a daily basis. Therefore, high attrition in this study may have
occurred because these participants showed lower levels o f self-efficacy, thus
discontinuing treatment because they could not “buy into the idea” that they were
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capable o f actively learning and utilizing helpful coping strategies (Davis & Addis,
1999, p. 347).
The high attrition rate in this study possibly could have also been due to
participants’ holding discrepant etiological and treatment beliefs. Furthermore,
patients may have discontinued treatment if they felt a relief from depressive
symptoms, thus assuming treatment was no longer warranted. Family and friends can
also create an environment that fails to support a patient’s response to treatment,
which increases the risk o f patient dropout. Many other process variables, such as the
patient’s perceptions o f the therapeutic relationship and sociodemographic variables,
have been shown to affect premature dropout. For instance, research shows that
minorities, patients who are younger, and those who are single/living alone are more
likely to drop out o f treatment (Organista, Munoz, & Gonzalez, 1994). Davis and
Addis (1999) report that attrition studies consistently underscore the importance o f
such process variables that illustrate the process by which attrition occurs. A better
understanding o f such factors may clarify why participants prematurely discontinue
treatment.
Because a clear majority o f dropouts in the current study did not give
particular reasons for termination and were unable to be contacted, it is impossible to
know exactly why each person prematurely ended treatment. It may be important to
note that some studies show that increased depressive psychopathology is correlated
with higher levels o f attrition (Fanner, Locke, Liu, & Moscicki, 1994; Murphy,
Carney, Knesevich, Wetzel, & Whitworth, 1995). But in this investigation, increased
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psychopathology did not appear to be a causal factor in premature termination, as
those who dropped out were not significantly more depressed than those who
completed the study, according to initial pretreatment BDI-H and RHRSD scores.
A number o f preventative interventions that target attrition have been cited in
the literature as decreasing the risk o f dropout For instance, Brent, Holder, Kolko,
Birmaher, Baugher, Roth, Iyengar, & Johnson (1997), report that dropouts have been
shown to be more hopeless than those who continue in treatment Therefore ones
hopelessness about the course o f treatment could be targeted early on in order to
enhance compliance. Also helpful may be to address attrition directly with the
participant from the beginning o f treatment, while making sure the therapist/
participant agree on the conceptualization o f his/her problems and the goals and tasks
o f therapy. Psychotherapy studies report a threefold increase in attrition rates when
therapists ignore these issues (Epperson, Bushway, & Warman, 1983).
Because o f high rates o f withdrawal, in conjunction with the lack o f further
post-test and follow-up data in this study, the generalizability and external validity o f
the results were compromised. Even after collapsing the two treatment groups, the
sample size remained low, which may have had an afreet on the power o f the study to
detect real differences i f they existed. Also limiting this investigations’
generalizability may have been the restrictive exclusion criteria employed during
recruitment, which in turn, led to studying a narrowly defined population. Although
common practice in clinical trials, this limits our ability to generalize our findings to
the full range o f people with depression who seek treatment in a typical service
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setting. Though, it would be impossible to establish the efficacy o f depression
treatment in every conceivable subgroup o f depressed individuals, our focus on a
small subset o f people with “pure” depression accents how little practicing clinicians
know about comprehensive groups o f depressed people (Zimmerman, Mattia, &
Postemak, 2002). Because the presence o f simultaneous psychiatric disorders can
greatly modify treatment outcome, it has been repeatedly suggested that researchers
go beyond the study o f “pure” depression and broaden their samples to include people
with comorbid diagnoses, such as anxiety and personality disorders, and suicidal
patients (Nezu, Nezu, Trunzo, & McClure, 1998).

Future Investigation and Conclusion
One direction for future BA research may include the obvious move to
broaden the range o f patients and settings in which BA appears to be effective. For
instance, testing the effectiveness o f BA in other “real-world” and naturalistic settings
(e.g., private practice), with less stringent inclusion criteria (e.g., include those
exhibiting suicidal behaviors and/or other comorbid Axis I and II disorders) could
potentially increase the generalizability o f the results.
Along similar lines, future research might test out BA with those suffering
from a more severe and chronic depression. While all but two participants in this
study reported their depression to be recurrent, depression levels fell on the cusp
between moderate and severe, according to the BDI-II. Future studies might consider
a sample in which BDI-II scores average 30 and higher, placing them in the severe
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category o f symptomatology. The severity and chronicity o f this disorder has
widespread community implications as both have been correlated with a higher
financial burden to our national community. Research suggests that the more severe
and chronic one’s depression, the more days he or she will lose at work, thus
decreasing overall work productivity (Lecrubier 2001). Given this evidence, it seems
imperative that future BA investigations are geared toward preventing and treating
those suffering from a more severe and chronic depression.
Because o f the aforementioned relapse rates amongst this group, future
investigations might also employ a parametric research strategy, such as exploring a
trial o f BA that includes a specified number o f intermittent booster sessions. For
example, Nezu et al. (1998) suggests that for an individual with a history o f symptom
recurrence, semiannual “depression check-ups” that focus on relapse prevention
techniques m aybe useful to maintain treatment gains (p. 509).
While it’s important to know whether a clinically significant reduction in
symptoms has occurred, it is also o f central clinical significance to determine whether
the patient’s quality o f life (e.g., health status, functional performance, life
satisfaction, standard o f living, etc.) has improved (Gladis, Gosch, Dishuk, & CritsChristoph, 1999). Thus, in order to expand our view o f clinical significance, future
investigation may use other assessment tools that assess a combination o f symptoms,
level o f functioning, but also quality o f life. More recent instruments, developed
specifically as quality o f life measures for depressed patients, such as the Quality o f
Life in Depression Scale (Hunt & McKenna, 1992) and the SmithKline Beecham
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Quality o f Life Scale (Stoker, Dunbar, & Beaumont, 1992) may be employed along
with more traditional measures as the BDI-H and RHRSD. As noted by Gladis et al.
(1999), a therapeutic intervention is only fully evaluated when its assessment tools
expand beyond symptom severity and the researcher documents its wide effects on all
domains.
The inclusion o f quality o f life assessments also has implications in the area o f
managed care, as providers are developing their own parameters for mental health
that include a wide array o f criterion, many o f which bear on the quality o f life.
Moreover, managed care providers frequently determine the length and type o f
treatment under the quality o f life umbrella, which includes such indicators as life
satisfaction, social relationships, and work performance. In sum, the use o f quality o f
life measures can be viewed as a necessary adjunct to statistical approaches o f
defining clinical significance and meaningful change (Jacobson & Traux, 1991).
In order to determine which specific BA interventions are most “necessary,
sufficient, and facilitative” o f therapeutic change (Kazdin, 1992, p. 142), a final
direction may be to conduct an investigation that dismantles BA. This could assist
clinicians in the identification o f BA techniques that are more “user-friendly” for both
the patient and therapist. Moreover, such fine-tuning o f BA may allow researchers
and practitioners to understand the fundamental mechanisms o f action in regard to
decreasing overall depressive symptomatology.
Finally, it is important to acknowledge that BA may not be an effective and
preferred therapeutic tool for every person suffering from depression. For instance, it
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has been suggested by Addis & Jacobson (1996) that patients who show a strong
tendency to search for the causes o f their depression are less likely to experience a
reduction in depressive symptoms with BA treatment. The examination o f such
causes may ultimately inhibit and prevent attempts at making meaningful behavior
changes, thus maintaining one’s depression. Because each depressed person shows
great variability in personal characteristics such as life circumstances, symptoms,
developmental history and biological makeup, to suggest BA as the ultimate tool
capable o f solving society’s depression epidemic would be to ignore individual
variability (Nezu, 1987).
In conclusion, the results o f this investigation affirms that BA shows great
promise as an effective treatment strategy for both medicated and unmedicated
individuals suffering from Major Depressive Disorder. It has been proposed that one
may not need to implement the full CBT treatment package in order to see significant
reductions in symptoms, making BA a sufficient and cost-effective therapeutic tool.
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Insert letter here
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TREATMENT INGREGRITY CHECKLIST
Subject Number ______

Session Number

Therapist_

1. Client filled out the BDI-II—beginning of session
2. Items on BDI-II were reviewed
3. Therapist & Client set agenda
4. Therapist & Client discussed agenda items
5. Therapist & Client discussed homework (from last week)

_

6. Therapist implemented Behavioral Activation interventions
•

Functional Assessment

•

Mastery & Pleasure Ratings o f Activities

•

Daily Activity Schedule Review

•

Assigning Activities to Increase Sense o f Mastery or Pleasure _

•

Explained ABC Model to Client

•

Encouraged an Active Rather than Passive Approach

•

Graded Task Assignments

•

Mental Rehearsal o f Assigned Tasks/Activities

•

Examined Alternative Behaviors in Different Situations

•

Role-Playing Behavioral Assignments

•

Maximizing the Likelihood of Homework Success

•

Distraction from Problems or Unpleasant Events

•

Avoiding or Limiting Exposure to Unpleasant Situations/People

•

Direct Behavioral Instruction

•

Taught Client to Give Themselves Rewards

•

Dealt with Specific Behavior Problems (e.g., sleep)

•

Training-Social Skills Deficits

_

7. Therapist did use Cognitive Interventions
•

Attempted to Change Cognitive Distortions

•

Addressed Automatic/Dysfunctional Thoughts

•

Instructed Client to Record Automatic/Dysfunctional Thoughts

•

Reality Testing o f Automatic/Dysfunctional Thoughts

8. Therapist did not use Cognitive Interventions
9. Therapist/Client discussedfollowing week homework
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RECRUITMENT SCRIPT
“The Clinical Researchers at Western Michigan University are conducting a study to
assess the effectiveness of a psychological treatment for depression. The treatment is
designed to break the cycle o f your depression and past research has shown this therapy to be
very effective with adults. Treatment would take place once a week for 10 consecutive
weeks and sessions will last approximately 60

minutes.

If you are experiencing problems with depression, you are encouraged to schedule an
appointment for an intake interview to determine if you qualify for acceptance into the study.
Participation in an interview in no way obligates you to participate in the study, but it serves
to give both you and the researchers a better understanding of how appropriate the therapy
would be for you. If you are accepted into the study, you would be expected to complete the
10-week course of treatment that would require approximately 60 minutes o f your time each
week. In addition, you would be expected to perform certain tasks between therapy sessions
that are aimed at relieving your depression.
Would you like me to go ahead and proceed? I have a few questions I would now
like to ask you?”
1.

"Are you currently taking any medication fo r psychological problems? ”

Ifves. “what?" ____________________________________________________
2. Ifves. explain- “In order to participate , we ask that you are stabilized on your
medication, meaning you must have been taking itfo r at least 6 weeks. When did you
initially start taking your medication? ” DATE_________ Proceed to Question #3.

3 . “Are you currently participating in any sort oftherapy treatmentfar any psychological
conditions? "________________

Ifves. expIain-“/h order to participater we ask that you not be in another concurrent
psychosocial treatment.” Give referrals.
If no. ask participants: “ Would you like to come info r an intake? ”
•

Ifves. explain~“I w ill pass your name and phone number along to my assessor and
he/she w ill call you within the nextfew days to schedule your intake appointment.

98

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

Appendix D
Consent Form

99

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

Western Michigan University
Department o f Psychology
Agreement to Participate in Research
Principal Investigator: C. Richard Spates, Ph.D.
Research Associate: Jenifer M. Cullen, M A .
I ,____________ have been invited to participate in a research project entitled
“Testing the Effectiveness o f Behavioral Activation Therapy in Acute Treatment o f
Unipolar Depression”. I have been told that this research is intended to measure the
efficacy o f Behavioral Activation Treatment as a therapeutic tool to treat individuals
suffering from Unipolar Depression. I have been told that this project is Jenifer M.
Cullen’s dissertation project.
My consent to participate in this project indicates that at the initial intake
interview I will be asked to complete one 10-minute multiple choice inventory, along
with a brief 5-minute personal information survey. In addition, I will be given two
psychological interviews that should take no longer than one hour to administer.
Only those persons who qualify for a diagnosis o f Unipolar Depression and who are
not enrolled in some other concurrent psychosocial therapy will be eligible to
participate. A ny other diagnoses will exclude me from the study.
If I am eligible for the study, I will be randomly assigned to one o f two
treatment conditions. In one condition, I will immediately begin Behavioral
Activation treatment for depression. In the second condition, Behavioral Activation
treatment will be delayed for approximately six weeks. A t the end o f the six-week
period, I will again be tested with a 10-minute psychological questionnaire and given
a 10-minute psychological interview. I will begin treatment immediately thereafter.
Both groups will receive treatment for 10 weeks and will be tested weekly with the
same 10-minute multiple choice survey. At the end o f the 10-week Behavioral
Activation treatment I will again be asked to complete the 10-minute multiple choice
survey and then be interviewed with the two psychological interviews given
previously. I will also be asked to complete a 5-minute Client Satisfaction Survey. I
have also been told that three months after treatment has ended, I will be asked to
return to the clinic to complete the same 10-minute multiple choice survey and be
interviewed a last tim e with the two psychological interviews already given. It has
been explained to me that there is a possibility that treatment sessions may be
videotaped to assure therapy is assuredly executed. Videotapes will be stored in a
locked file drawer and only project personnel w ill have access to those tapes.
As in all research, there m aybe unforeseen risks to the participant I f an
accidental injury occurs, appropriate emergency measures will betaken; however, no
compensation o r treatment will be made available to m e except as otherwise specified
in this consent form. I realize that one potential risk o f my participation in this
project is that I m ay experience unpleasant emotions, including anger, frustration,
depression, and disappointment, as I recall m y problems and experiences and actively
work to change certain behaviors in order to reduce m y depression. I have been told
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that the Psychology Clinic is prepared to make a referral should emergency care
become necessary. I will be responsible for the cost o f emergency care should such
care become necessary.
One way in which I may benefit from this study is that, as a result o f receiving
treatment, I may experience a reduction o r elimination o f my depressive symptoms.
In addition, I may benefit from the knowledge that is gained by this research, as can
others in the community who suffer from Unipolar Depression.
I have been told that all research information collected from me will be kept
confidential. This means that my name will not appear on any research
questionnaires I complete o r on any other research forms that contain personal
information I have provided. I further understand that these forms will be kept in a
research folder in a locked file cabinet in this clinic during my participation in the
study. I also have been told that the policy o f this clinic requires that progress notes
and further information about me be recorded and placed in a treatment folder. This is
necessary because by participating in this study, I am also a client o f this clinic.
However, I realize that the information in m y treatment folder belongs to the clinic
and may not be used as data for this study. I have been told that forms used in this
study may be duplicated and placed in m y treatment folder where they will be
retained until they are destroyed along with the rest o f the papers in my treatment
folder according to the policies o f the clinic. At the end o f m y participation in the
study m y research folder will be moved to a locked cabinet in the Department o f
Psychology where it will be stored for at least three years after the completion o f this
study. It will then be destroyed. I have been told that Jenifer Cullen will keep a
separate m aster list with the names and research code numbers o f participants from
this clinic. The m aster list will be the only link between the data on the recording
forms and my identity. The master list will be destroyed once all data has been
collected and analyzed.
I have been advised that I may refuse to participate o r quit at any time during
the study without prejudice or penalty or effect on m y relationship with Western
Michigan University. I am aware o f alternative treatment services should this be the
case. If I have any questions or concerns about this study, I may contact either Dr.
Richard Spates at (616) 387-4329 or Jenifer Cullen at(616) 553-9836. If I have
questions about my rights as a research participant o r about any other aspects o f m y
participation, I also may contact the Chair o f the Human Subjects Institutional
Review Board at (616) 387-8239 or the Vice President for Research at (616) 3878293 with any concerns that I have. This consent document has been approved for
use for one year by the Human Subjects Institutional Review Board (HSIRB) as
indicated by the stamped date and signature o f the board chair in the upper right
com er o f all pages. My signature below indicates that the purpose and requirements
o f the study have been made clear and that I agree to participate.
Signature_______________________________________
D ate_________________________________
101

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

Appendix E
Demographics Questionnaire
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D E M O G R A P H IC S Q U E S T IO N N A IR E
R e s e a rc h C o d e N u m b e r : ________
A d d r e s s :____________________

A g e : __________

DOB:

Em ergency C ontact Telephone # __________
G ender: (Circle one)

Male

Female

E thnicity: (Mark best choice)
• African Am erican______
• American Indian______
• Asian American______
• Alaskan Am erican______
• Caucasian (w hite)______
• Hispanic______
• International/non US resident_____
• M ultiracial_____
• Other (please specify): ___________
R elationship Status: (Mark best choice)
• Single, never m arried______
• Living with significant other______
• Separated______
• Divorced______
• M arried______
Y ears o f Education: (Mark best choice)
• Less than 12 years______
• 12 years or GED______
• More than 12 and less than 16 years
• 16 years______
• 16+ years______
Household Incom e: (Mark best choice)
• Under $10,000 per year______
• $10,000-520,000 per year______
• $20,000-530,000 per year______
• Over $30,000 per year______
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A re you currently receiving treatm en t fo r depression?
• Y es______
• N o ______
• If yes, what type o f treatment? (Mark all that apply)
• Medication Treatm ent______
• Hospital (Inpatient or Partial Hospitalization) C are_____
• Pastoral C are______
• Individual Therapy______
• Group Therapy______
• Support G roup______
Have you
•
•
•

been in treatm ent fo r depression in the past?
Y es______
N o ______
If yes, how many episodes o f treatment have you been through? _

A re you cu rren tly taking prescription medication(s) fo r depression?
• Y es______
• N o______
• If yes, what medication(s) are you taking and what is the dosage?

H av e y o u ta k e n p r e s c r ip tio n m e d ic a tio n (s) f o r d e p re s s io n in th e p a s t?

•
•
•

Y es______
N o ______
If yes, what m edication(s)?________________________________

A r e y o u c u r r e n tly in tr e a tm e n t f o r a n y p sy ch o lo g ical c o n d itio n (s) o th e r th a n
d e p re s s io n ?

•
•

Yes (please specify)_____________________________________
N o ______

H a v e y o u b e e n tr e a te d f o r a n y p sy ch o lo g ical c o n d itio n s(s) o th e r th a n d e p re s s io n
in th e p a s t?

•
•

Yes (please specify)_____________________________________
N o ______

C u r r e n t S tre s s o rs :
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Appendix F
Beck Depression Inventory—Second Edition
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The Beck Depression Inventory-Second Edition is copyrighted by Aaron T. Beck,
1996. Persons interested in obtaining information regarding this instrument should
contact The Psychological Corporation, 555 Academic Court, San Antonio, Texas
78204-2498.
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Appendix G
Revised Hamilton Rating Scale for Depression
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The Revised Hamilton Rating Scale for Depression is copyrighted by W. L. Warren,
1994. Persons interested in obtaining information regarding this instrument should
contact Western Psychological Services, 12031 Wilshire, Boulevard, Los Angeles,
California 90025-1251.
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Master List
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M aster List o f Subjects
Name

Last 4

I._
2
3._
4._
5._
6 ._

7._
8 ._

9._
10.

II.
12- .
13- .
14-.
15-.
16..
17.
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Research#

Appendix I
Universal Data Collection Form
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Universal Data Collection Form
Assessment Information for Participant #
Intake Interview:
• BDI-II Score________
• RHRSD Score________
• SCID DX:
• Axis I
____

•

Axis II

•

Axis III

•

Axis IV

•

GAF Score

B D I-II sco res f o r W A IT L I S T C O N D IT IO N O N L Y d u r in g 6 -w e e k w a it p e rio d

•
•
•

B D II_____
BDI 2 _____
BDI 3

B D I-Q sco res d u r in g 1 0 -w eek tr e a tm e n t:

•
•
•
•
•
•
•
•
•
•

Week 1 ______
Week 2 ______
Week 3 ______
Week 4 _______
Week 5 ______
Week 6 ______
Week 7 ______
W eekS______
Week 9 ______
Week 10
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P o s t-tre a tm e n t:

•
•
•

B D i-n__
RHRSD _
SCID DX:
• Axis I
•
•

Axis II
Axis in

•

Axis IV

•

GAF Score

3 M o n th F o llo w -U p :

•
•
•

•

b d i - i i _____

RHRSD____
SCID DX:
• Axis I
•

Axis II

•

Axis III

•

Axis IV

•

GAF Score______________________

All data collection Complete: Initials

Date
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